Abstract

The functions of γδ T cells are enigmatic, and these cells are often considered as evolutionary remnants of well-characterized αβ T cells. However, their conservation throughout evolution suggests that γδ T cells are biologically unique. In ruminants, γδ T cells expressing the workshop cluster 1 (WC1) scavenger receptor comprise a large proportion of circulating lymphocytes, suggesting these cells are biologically relevant and functionally different from αβ T cells. In fact, bovine WC1+ γδ T cells can act as APC for αβ T cells, indicating they may express genes encoding proteins associated with innate immunity. The present study was designed to compare immune function gene expression profiles of clonal populations of WC1+ γδ and CD4+ αβ T cells derived from the same animal, which respond to major surface protein 2 (MSP2) of the intraerythrocytic rickettsial pathogen of cattle, Anaplasma marginale. Gene expression profiles of activated T cell clones were compared using a microarray format, and differential gene expression was confirmed by real-time RT-PCR and protein analyses. We demonstrate that although MSP2-specific αβ and γδ T cell clones express many of the same genes, γδ T cell clones express high levels of genes associated with myeloid cells, including chemokines CCL2, CXCL1, CXCL2, CXCL6, and surface receptors CD68, CD11b, macrophage scavenger receptor 1, macrophage mannose receptor, and galectin-3. It is important that many of these genes were also expressed at higher levels in polyclonal WC1+ γδ T cells when compared with CD4+ αβ T cells selected from peripheral blood.

INTRODUCTION

The functions of γδ T cells are still poorly defined, despite their discovery in 1986 [1]. Several of the well-characterized properties of αβ T cells are shared by γδ T cells, such as cytolytic effector cell function and expression of related perforins, granulysin, and Fas/Fas ligand (FasL), as well as secretion of T cell cytokines [2]. However, restricting the characterization of γδ T cells to examining those functions typically associated with αβ T cells potentially biases or limits a more complete understanding of γδ T cell biology.

Cattle have large numbers of circulating γδ T cells. In young ruminants, γδ T cells can comprise up to 70% of circulating leukocytes, with the percentage decreasing to 10–25% as animals approach maturity [3, 4]. The majority of γδ T cells in the circulation expresses a unique scavenger receptor, workshop cluster 1 (WC1), and does not express CD2, CD6, or CD8, whereas the majority of γδ T cells in the spleen and intestine expresses these CD molecules but lacks the WC1 molecule [5]. Although genes homologous to WC1 have been identified in humans and mice, they are not expressed in species other than ruminants and pigs [6, 7]. WC1+ γδ T cells in ruminants express inflammatory cytokines [8, 9] similar to the Vγ9Vδ2 subset in humans [10]. WC1+ γδ T cells also migrate to sites of infection, suggesting an inflammatory role [11], which was confirmed in global gene expression analyses on these cells [12, 13].

The high percentage of circulating WC1+ γδ T cells in ruminants suggests that these cells are important and distinct from αβ T cells. In addition, the decrease in percentage of WC1+ γδ T cells as animals reach adulthood indicates a role in immune defense prior to the development of a fully competent immune system [14]. In support of a potential role for γδ T cells in bridging innate and adaptive immunity, WC1+ γδ T cells can act as APC for αβ T cells, a result recently repeated with human γδ T cells [15, 16]. Previous functional gene expression studies have compared WC1+ and WC1 γδ T cells [12, 13] and sorted polyclonal γδ and αβ T cell populations by serial analysis of gene expression (SAGE) [17]. The current study was designed to determine whether WC1+ γδ T cells and CD4+ αβ T cells, which respond to the same antigen, have different gene expression profiles and specifically, whether WC1+ γδ T cells differentially express genes associated with innate immune cell function. To this end, two independently derived sets of WC1+ γδ and CD4+ αβ T cell clones, which respond to major surface protein 2 (MSP2) of Anaplasma marginale, an intraerythrocytic rickettsial pathogen of cattle, were compared [8, 18]. T cell clones were used, as MSP2-responsive γδ T cells are rare in MSP2-immunized cattle, and γδ T cells enriched from PBMC did not respond to this antigen. Gene expression profiles of activated T cell clones were compared using an oligonucleotide microarray format, and the differential expression of differentially regulated immune function genes was confirmed by real-time RT-PCR and by protein or functional analyses, where possible. We demonstrate that although CD4+ αβ and WC1+ γδ T cells do express similar levels of many of the same genes, interesting differences between these two cell types were also revealed. It is important that WC1+ γδ T cells expressed higher levels of genes more commonly associated with macrophages rather than T lymphocytes. To determine if the myeloid cell-associated gene expression pattern was generally representative of circulating WC1+ γδ T cells, a similar comparison was performed with WC1+ γδ and CD4+ αβ T cells sorted from peripheral blood. Many of the differentially regulated genes expressed by the T cell clones were similarly expressed by polyclonal populations.

MATERIALS AND METHODS

T cell clones

WC1+ γδ T cell clone 61.1G11 was isolated from MSP2-immunized Holstein steer 98B61 as described previously [8, 18]. γδ T cell clone 61.3G3 as well as CD4+ αβ T cell clones 61.10.2D7 and 61.3H5 were isolated from the same animal (98B61) in different experiments by limiting dilution cloning as described [8, 18]. The cell lines and clones were stimulated weekly with T cell growth factor (TCGF), 5 μg/ml A. marginale MSP2 peptide P10 and irradiated PBMC as a source of APC. Peptide P10 (VAGAFARAVEGAEVIEVRAIGSTSVMLNAC) is a 30-amino acid peptide in the carboxy-terminal, conserved region of MSP2, which contains epitopes for CD4+ αβ T cells and WC1+ γδ T cell clone 61.1G11 [8, 18, 19]. After expansion of the clones, cell surface phenotypes were determined by flow cytometry, and antigen responsiveness was analyzed with proliferation assays. All T cell clones were cryopreserved at the time they were responding to antigen (see Table 2) in 10% DMSO in heat-inactivated FBS and were thawed and restimulated with antigen, TCGF, and APC 1 week prior to stimulation with Con A plus IL-2 when RNA was isolated for gene expression analysis. Animals were housed and maintained according to university guidelines.

Positively selected cell populations

WC1+ γδ T cells and CD4+ αβ T cells were positively selected using anti-WC1 mAb BAQ4A or anti-CD4 mAb CC8 (provided by Chris Howard, Institute for Animal Health, Compton, UK) using goat anti-mouse IgG-coated MACS MicroBeads following the manufacturer’s instructions (Miltenyi Biotec, Auburn, CA). The cells were passed through two columns to increase purity, which was greater than 97%, as determined by flow cytometry (data not shown).

Cell surface phenotypic analysis

Differentiation markers on T cell clones were analyzed within 1 week of gene expression analysis by indirect immunofluorescence and flow cytometry as described previously [20]. The mAb used were specific for bovine CD2 (mAb MUC2A), CD3 (mAb MM1A), CD4 (mAb CACT 138A), CD8 (mAb CACT 80C and BAT 82B), the δ chain of the γδ TCR (mAb CACT 61A or GB21A), WC1 (mAb BAQ 4A), CD14 (mAb CAM 36A), and CD11b (mAb MM10A). These mAb were purchased from the Washington State University Monoclonal Antibody Center (Pullman). Following staining, cells were fixed with 1% paraformaldehyde and analyzed by flow cytometry (FACSort, BD Biosciences, San Jose, CA). Viable cells were gated on scattering characteristics, and analysis was performed with FCS Express 2 (De Novo Software, Thornhill, Ontario, Canada).

Lymphocyte proliferation assays

The proliferative response of clone 61.1G11 to A. marginale, MSP2, and peptide P10 was described previously [8, 18, 19]. Proliferation assays for all clones were performed in duplicate wells of round-bottomed, 96-well plates for 4 days, 7 days prior to stimulation for gene expression analysis, and 7 days after the last stimulation with antigen and irradiated PBMC as a source of APC. Positively selected cell populations were assayed at a concentration of 2 × 105 cells/ml for 7 days at the time of sorting and stimulation for gene expression analysis. For T cell clones 61.1G11 and 61.10.2D7, the proliferation assay was performed immediately prior to freezing cells, which were thawed and restimulated with TCGF, 10 μg/ml A. marginale Florida strain homogenate and irradiated PBMC as APC for 1 week prior to stimulation with Con A plus IL-2 (see below) and mRNA collection. Clones 61.3G3 and 61.3H5 were never frozen, and proliferation assays were performed 7 days before stimulation and mRNA collection. T cells (3×104 cells/well) were cultured in duplicate wells in a total volume of 100 μl complete medium containing 2 × 105 APC/well and antigen. Antigens consisted of 10 μg/ml A. marginale Florida strain homogenate, native, gel-purified MSP2, synthetic peptides of MSP2 including P10, or negative-control antigens uninfected RBC (URBC) membranes and MSP2 peptide P12 (VPYACAGIGGNFVSVVDGHINPKFAYRVKA) [19]. Protein concentrations in all antigen preparations were determined by the Bradford assay. To determine proliferation, cells were radiolabeled for the last 18 h of culture with 0.25 μCi [3H]thymidine (Dupont New England Nuclear, Boston, MA), and radiolabeled nucleic acids were harvested and counted with a Betaplate 1205 liquid scintillation counter (Wallac, Gaithersburg, MD). The proliferation assay was performed two times for each clone with similar results. Results are presented from a representative experiment as the stimulation index (SI), determined as the mean cpm of replicate cultures of cells plus antigen/the mean cpm of replicate cultures of cells plus medium. A SI of ≥3.0 was considered statistically significant [21].

Cell stimulation and RNA collection

To obtain RNA for microarray and real-time RT-PCR analyses, T cell clones were obtained 7 days after the last stimulation with antigen and APC and were washed three times. Cells were cultured with 5 μg/ml Con A and 5 U/ml recombinant human IL-2 (Boehringer Mannheim, Indianapolis, IN) at 4 × 106 cells/well in 24-well plates in the absence of APC. RNA was collected after 6 h using the TRIzol reagent (Gibco BRL, Gaithersburg, MD) as described by the manufacturer. RNA levels were determined by spectrophotometry and in oligonucleotide arrays, RNA quality was assessed using an Agilent 2100 bioanalyzer (Palo Alto, CA). Clones 61.1G11 and 61.10.2D7 were stimulated identically and used for the oligonucleotide array and real-time RT-PCR analyses. Clones 61.3G3 and 61.3H5 as well as positively selected WC1+ and CD4+ sorted cells were stimulated similarly and used for real-time RT-PCR analyses.

Bovine oligonucleotide microarray

RNA extracted from WC1+ γδ T cell clone 61.1G11 and CD4+ αβ T cell clone 61.10.2D7 was used to probe the Affymetrix GeneChip® bovine genome array (Affymetrix, Santa Clara, CA), which represents ∼23,000 transcripts based on Unigene Build 57 (April 2004) and GenBank sequences. cDNA amplification and synthesis of biotin-labeled cRNA were performed with the one-cycle, target-labeling protocol with 1.8 μg total RNA as described in the GeneChip® Expression Analysis Technical Manual (March 2004). Hybridization was performed with 15 μg cRNA. Washing and staining were performed in the GeneChip® Fluidics Station 450 using the Midi_euk2v3 protocol. Chip scans were performed on the Affymetrix GeneChip® Scanner 3000. GeneChip® operating software (GCOS v.1.1, Affymetrix) [22, 23] was used for data collection and analysis with scaling to an arbitrary target intensity of 500, and further analysis was done using Microsoft Excel. The cutoff for inclusion in the differentially regulated gene category was a 2.0-fold difference between αβ and γδ T cell RNA expression levels. Complete microarray data are available online, Gene Expression Omnibus Accession Numbers GSM52151 and GSM52152.

Real-time RT-PCR analysis of selected genes

In separate experiments, the relative expression levels of selected genes of interest were compared in γδ T cell clone 61.1G11 and αβ T cell clone 61.10.2D7 or γδ T cell clone 61.3H5 and αβ T cell clone 61.3G3 by using real-time RT-PCR. RNA (1 μg) from each clone was reverse-transcribed using the iQ iScript cDNA synthesis kit (Bio-Rad, Hercules, CA) according to the manufacturer’s specifications. Relative amounts of mRNA were analyzed by using the relative quantitation method with a reference standard curve of RNA isolated from unstimulated PBMC using the TRIzol method (User Bulletin #2, Applied Biosystems, Foster City, CA). The gene symbols, forward and reverse primers, product lengths, and GenBank accession numbers of the sequences used to design the primers are listed in Table 1. PCR was performed using SYBR green I (Bio-Rad) in 25 μl reactions. Primers were used at a final concentration of 100 nM. Reactions were performed with a melt temperature of 95°C for 10 s and extension at 58°C for 60 s with the exception of MSR1, which had an extension temperature of 56.4°C. A melt curve was performed for each reaction to confirm uniformity of the amplicons. The standard curve was generated using duplicate samples of tenfold serial dilutions of cDNA from unstimulated PBMC, and unknown samples were run in triplicate. cDNA for the γδ clone and the αβ clone was generated without RT and used to rule out genomic DNA contamination. After conversion to relative concentrations using the standard curve, each value was normalized to 18S rRNA values, and ratios were determined.

Cytokine and NO determinations

T cell clones were harvested as before, 7 days after culture with antigen plus irradiated APC, and were subsequently cultured in 24-well plates at 1.3 × 106 cells per ml with Con A plus IL-2 in the absence of APC. Supernatants collected after 24 h from αβ T cell clone 61.10.2D7 and γδ T cell clone 61.1G11 as well as identically stimulated, positively selected CD4+ αβ T cells and WC1+ γδ T cells were used to measure IFN-γ, TNF-α, IL-10, and NO. All assays were statistically analyzed with one-tailed Student’s t-test.

The levels of IFN-γ in supernatants diluted 1:4–1:100 were determined by ELISA (Bovigam, CSL Ltd., Parkville, Victoria, Australia) and compared with a standard curve obtained with a supernatant from a Mycobacterium bovis-purified protein derivative-specific T cell clone, which contained 440 U IFN-γ/ml (previously determined by the neutralization of vesicular stomatitis virus) [25]. In the assay, 1.7 ng corresponds to ∼1 unit IFN-γ [26].

The TNF-α capture ELISA was done as described previously [27, 28]. Briefly, Immulon II ELISA plates (Dynax Technologies, Chantilly, VA) were coated with anti-bovine TNF-α mAb 1D11-10 [provided by Veterinary Infectious Disease Organization (VIDO), Saskatoon, Saskatchewan, Canada]. Bound TNF-α was detected by incubation with a rabbit anti-TNF-α serum (VIDO) and subsequently, with biotinylated goat-anti rabbit IgG (heavy and light chains; Zymed Laboratories, San Francisco, CA), streptavidin-alkaline phosphatase (Gibco BRL), and the substrate p-nitrophenyl phosphate (AP-Yellow BioFX Laboratories, Owings Mills, MD). Samples were analyzed by comparison with a standard curve prepared using recombinant bovine TNF-α (VIDO), diluted to 0.02–10.0 ng/ml.

The IL-10 capture ELISA was done as described previously [24] with the following modifications. Black 96-well microplates (Porvair, Shepperton, UK) were incubated overnight at 4°C with capture mAb CC318 at 6 μg/ml in coating buffer. Following blocking with PBS containing Tween 20 (PBST), containing 1% BSA, 100 μl cell culture supernatants were added to each well and incubated for 1 h. Following six washes with PBST, 100 μl 2 μg/ml biotin-labeled secondary mAb CC320 was added to each well and incubated for an additional 1 h. The plates were washed six times with PBST, and 100 μl of the Super Signal ELISA Femto maximum sensitivity substrate (Pierce Biotechnology, Inc., Rockford, IL) was added, and the plates were evaluated within 5 min. The relative light unit value was read on a Betaplate 1205 liquid scintillation counter and luminometer (Wallac). The amount of IL-10 in culture supernatants was determined by comparison with a standard curve using recombinant bovine IL-10, where 1 unit IL-10 is the reciprocal dilution of recombinant IL-10 expressed in COS-7 cell supernatants, which inhibited IFN-γ production by M. bovis-specific T cells stimulated with a purified protein derivative by 50% [24]. The results are expressed as units/ml IL-10.

Nitrite (NO2) present in culture supernatants was measured in a Griess assay [28, 29]. Briefly, culture supernatants were transferred (50 μl/well) to 96-well, flat-bottomed plates, and 50 μl/well each 1% (w/v) sulfanilamide (Sigma Chemical Co., St. Louis, MO) in 2.5% H3PO4 and subsequently, 0.1% (w/v) naphthylethylenediamine dihydrochloride (Sigma Chemical Co.) in 2.5% H3PO4 was added to the supernatants, and the absorbance at 540 nm was compared with an NaNO2 standard curve. Results are presented as the mean μM concentration of NO2 in triplicate cultures ± 1 sd.

RESULTS

Response of clones to antigen

The two pairs of T cell clones, each comprised of one CD4+ αβ T cell clone and one WC1+ γδ T cell clone, were selected for this study, as they responded by proliferation to A. marginale MSP2, and one pair additionally responded to MSP2 peptide P10. WC1+ γδ T cell clone 61.1G11 was previously shown to proliferate in response to A. marginale MSP2 and to a conserved region peptide, P10, of this protein [8, 18]. αβ T cell clones 61.10.2D7 and 61.3H5 and γδ T cell clone 61.3G3 were more recently isolated from animal 98B61 in a similar manner. Proliferative responses of T cell clones to A. marginale, MSP2, and peptide P10 are shown in Table 2. Clones 61.3H5 and 61.3G3 responded to A. marginale and MSP2 but not peptide P10, whereas γδ T cell clone 61.1G11 and αβ clone 61.10.2D7 responded to all three antigens. In a separate assay, CD4+ αβ T cell clone 61.10.2D7 was tested with MSP2 and had a SI of 58.9 compared with a SI of 0.7 to negative-control URBC antigen. Positively selected CD4+ T cells from MSP2-immunized animals responded to A. marginale and MSP2, as demonstrated previously in other studies [30, 31], whereas the WC1+ T cells did not proliferate to antigen (data not shown).

Oligonucleotide array

Cells were harvested 7 days after culture with antigen and irradiated APC and then stimulated with IL-2 plus Con A for mRNA collection without APC to avoid potential contamination with RNA from APC. Furthermore, analysis of the T cell clones for CD3 and CD14 expression by flow cytometry after 7 days of culture and washing demonstrated that all cells were CD3+ and CD14, indicating there were no residual myeloid cells in the cultures. These cells appropriately expressed CD4 or the γδ TCR (Fig. 1). Comparison of gene expression in γδ and αβ T cells was first done with Con A/IL-2-stimulated γδ T cell clone 61.1G11 and αβ T cell clone 61.10.2D7 using the bovine oligonucleotide array. Transcripts (1343) were expressed at twofold or higher levels in the γδ T cell clone, and 606 transcripts were expressed at twofold or higher levels in the αβ T cell clone. Immune function-associated genes with increased expression in γδ or αβ T cell clones are listed in Table 3. As expected, γ and δ TCR mRNA was expressed at higher levels in the γδ T cell clone, 61.1G11. Conversely, αβ T cell clone 61.10.2D7 had higher levels of CD2, CD4, and α and β TCR mRNA. Two γ-chain TCR transcripts were expressed at higher levels in the αβ T cell clone, which is not unexpected, as the majority of αβ T cells has rearranged but not functional γ- and δ-chain genes. Genes not typically associated with T lymphocytes such as MSR1, MMR, TLR4, and chemokines CCL2, CCL8, CXCL1, CXCL2, and CXCL6 were up-regulated in the γδ T cell clone. The XCL1 chemokine, which is typically associated with CD8+ T cells, NK cells, mast cells, and γδ T cells, was highly expressed by the WC1+ subset of γδ T cells. In addition, CD68 and CD11b were expressed at higher levels in the γδ T cell clone. The oligonucleotide array results thus suggested that the γδ T cell clone had a phenotype which shared characteristics of myeloid cells.

Real-time RT-PCR analysis of genes expressed by γδ T cell clone 61.1G11 and αβ T cell clone 61.10.2D7

Thirty-eight genes were selected for real-time RT-PCR analysis to confirm differential expression by γδ and αβ T cell clones. The relative gene quantitation method using a standard curve was used to compare the differences in transcript levels in RNA isolated from clones 61.1G11 and 61.10.2D7. The differences predicted by the microarray and the actual differences in transcript levels identified by real-time RT-PCR are listed in Table 4. The expression patterns detected by the oligonucleotide array were confirmed for 31 of the 38 transcripts when analyzed by real-time RT-PCR. As observed with the oligonucleotide array, chemokines CCL2, CCL8, CXCL1, CXCL2, CXCL6, and XCL1 were expressed at higher levels in the γδ T cell clone. Similarly, as predicted from the microarray data, genes typically associated with αβ T cells such as RANTES (CCL5) and MIP-1α (CCL3) were expressed at similar levels in αβ and γδ T cells. Real-time RT-PCR analysis also confirmed up-regulated expression in γδ T cells of mRNA encoding TLR4, MSR1, MMR, and CD11b, a component of Mac-1, which are surface molecules typically associated with macrophages.

Protein expression and functional assays of γδ T cell clone 61.1G11 and αβ T cell clone 61.10.2D7

To assure that the increased transcript expression identified with the oligonucleotide array and by real-time RT-PCR analysis correlated with protein expression, protein levels were measured when possible based on availability of reagents. Cytokines TNF-α, IFN-γ, and IL-10 were compared using ELISAs, and NO production was analyzed using the Griess reaction, which measures nitrite in the supernatant (Table 5). The relatively large production of IFN-γ by clone 61.10.2D7 is typical of bovine CD4+ T cell lines and clones specific for MSP2 [19]. The amounts of cytokine or nitrite measured in supernatants corresponded with mRNA expression quantified by real-time RT-PCR. Furthermore, flow cytometric analysis showed significant expression of CD11b on γδ T cells but not αβ T cells, which again confirmed array and real-time PCR data (Fig. 2). Flow cytometry also showed that CD2, CD4, and CD6 were expressed on the αβ T cell clones but not on the γδ T cell clones (ref. [8] and data not shown), as predicted by the oligonucleotide array.

Real-time RT-PCR analysis of γδ T cell clone 61.3G3, αβ T cell clone 61.3H5, and WC1+ and CD4+ sorted populations

To determine if gene expression profiles obtained for clones 61.1G11 and 61.10.2D7 were unique to these cells or more generally representative of MSP2-responsive CD4+ αβ T cell and WC1+ γδ T cells, additional, real-time RT-PCR analysis was performed on another set of clones, γδ T cell clone 61.3G3 and αβ T cell clone 61.3H5. The clones selected for this comparison responded to A. marginale MSP2 but did not respond to peptide P10, unlike the previous set of clones (Table 2), indicating that the two pairs of clones are of different origins. Many of the comparisons of gene expression for the second pair of T cell clones were similar to those of the previous comparison (Table 6). Specifically, the majority of genes analyzed with the additional set of T cell clones had similar patterns of expression to those obtained by previous real-time PCR analysis of T cell clones. It is important that the γδ T cell clones expressed relatively high levels of CCL2, CXCL1, CXCL2, CXCL6 MSR1, MMR, galectin-3, CD68, and CD11b, genes that are generally associated with myeloid cells, as well as the γδ T cell-associated chemokine XCL1.

To determine whether the results obtained with cloned T cells specific for A. marginale MSP2 were representative of polyclonal cell populations, positively selected WC1+ T cells and CD4+ T cells were compared. This experiment demonstrated similar patterns of gene expression observed when comparing αβ and γδ T cell clones. When compared with clones 61.1G11 and 61.10.2D7, 16 of 20 genes analyzed had the same patterns of expression, and when compared with clones 61.3G3 and 61.3H5, 12 of the 20 genes had similar patterns of expression. Once again, genes typically associated with myeloid cells were expressed at much higher levels in positively selected γδ T cells than in αβ T cells. These genes included CCL2, CCL8, CXCL1, CXCL2, CXCL6, galectin-3, TLR4, CD68, and CD11b. The XCL1 chemokine was also up-regulated. These data suggest that the results obtained with T cell clones are representative of T cell populations selected from peripheral blood, although the majority of T cells in the population is not specific for MSP2.

DISCUSSION

We have postulated that WC1+ γδ T cells may express higher levels of genes typically associated with cells of the innate immune response rather than CD4+ αβ T cells. Comparison of gene expression in clonal populations of γδ and αβ T cells from the same individual, which respond to the same antigen, enabled us to determine whether γδ T cells and αβ T cells have differentially expressed immune response genes, by controlling for differences in antigen responsiveness. Our results show that the WC1+ subset of γδ T cells expresses higher levels of genes encoding chemokines and surface receptors, which are more typically expressed by myeloid cells, and therefore suggest that although γδ and αβ T cells may have some redundant functions, γδ T cells may function in a unique way during an inflammatory response.

Two primary hypotheses have been proposed to explain the preservation of γδ and αβ T cells throughout evolution. The first suggests that γδ T cells have effector functions similar to those of αβ T cells but as a result of their different mechanism(s) of antigen recognition, respond to atypical types of antigens. In fact, it has been demonstrated recently that murine γδ T cells interact with their ligand by a germ-line-encoded, single side-chain of the Dγ region [32, 33], which differs from antigen recognition by αβ T cells through complementary-determining region 3 (CDR3). The bovine WC1+ γδ and CD4+ αβ T cell clones used in this study also recognize antigen differently. Whereas CD4+ T cells are MHC class II-restricted, the γδ T cell clones are not [8]. In addition, sequence analysis suggested that γδ T cell clones do not recognize antigen through CDR3 [8]. The second hypothesis proposes that γδ and αβ T cells are functionally different. In support of this, γδ T cells have been shown to be uniquely involved in epidermal tissue repair and protection of normal airway function [34–36]. However, these hypotheses are not mutually exclusive. The αβ and γδ T cell clones analyzed in our study recognize MSP2 but have markedly different responses to the same stimulus, which strongly argues that WC1+ γδ T cells are functionally different from CD4+ αβ T cells, although many immune function genes are similarly expressed.

Of particular interest is the higher level of expression of genes in WC1+ γδ T cells, which are typically associated with myeloid cells, detected in clone 61.1G11 by oligonucleotide array and confirmed by real-time RT-PCR for this clone, clone 61.3G3, and a polyclonal population of WC1+ γδ T cells. These genes include chemokines and surface receptors CCL2, CXCL1, CXCL2, CXCL6, MSR1, MMR, galectin-3, CD68, and CD11b. The up-regulated expression of these genes in γδ T cells is not likely explained by contaminating APC, as flow cytometric analysis of the clones within 1 week of RNA extraction demonstrated their purity. Furthermore, as the T cell clones were cultured in an identical manner, any residual APC in the cultures should be the same for αβ and γδ T clones. Similarly, populations of T cells sorted immediately prior to stimulation were also highly pure and free of contaminating APC. Of particular interest is the consistent finding that genes commonly associated with myeloid cells were expressed at higher levels by γδ T cells in the three comparative experiments. Additional myeloid-associated genes expressed at higher levels by γδ T cells in two of the three comparative studies were TLR4 and CCL8.

CCL chemokines are chemoattractants for monocytes, NK cells, and activated T cells, and the CXCL chemokines attract granulocytes and naïve T cells. CCL2, CCL8, CXCL1, CXCL2, and CXCL6 are typically produced by macrophages, keratinocytes, endothelial cells, and stromal cells [37]. Conversely, XCLI, also known as lymphotactin, is the only member of the C group of chemokines and is typically produced by activated CD8+ T cells, NK cells, mast cells, and γδ T cells. CD68 is macrosialin, a sialoprotein typically associated with macrophages. MSR1 is associated with binding cell-wall components of Gram-positive and Gram-negative bacteria and endotoxin. MMR binds the bacterial carbohydrate, mannose, and is typically found on the surface of macrophages and endothelial cells. Galectin-3, also known as Mac-2, binds galactose and is abundant on macrophages. TLR4 binds LPS and is also found on phagocytic cells. CD11b is a component of Mac-1, which binds to ICAM-1, complement component 3, and fibrinogen, and is normally distributed on myeloid and NK cells. Many of these receptors are important in recognition of pathogen-associated molecular patterns, including LPS, and several have been shown to be functional in γδ T cells [38]. The expression by WC1+ γδ T cells of these chemokines and surface receptors is consistent with a role for these cells in recruiting inflammatory cells during infection.

Previous studies have compared gene expression in CD8+ WC1 and CD8 WC1+ γδ T cell subsets of cattle using sorted cell populations [12, 13, 17]. SAGE and microarray analysis suggested that γδ T cells express a myeloid phenotype [13] in that transcripts for MSR1, CD68, and TNF-α were expressed at higher levels in WC1+ CD8 γδ T cells when compared with CD8+ WC1 γδ T cells. These genes were also regulated differentially in our comparison of WC1+ γδ T cells with CD4+ αβ T cells and support the concept that WC1+ γδ T cells share properties of myeloid cells. The demonstration that bovine γδ T cells, including cultured WC1+ γδ T cells, present antigen to αβ T cells [15] is also consistent with WC1+ γδ T cells sharing functions associated with APC of myeloid origin and supports their role in bridging innate and adaptive immunity. More recently, professional APC function was documented for human γδ T cells [16], lending further support to the concept that γδ T cells have evolved to function in some ways like myeloid cells.

In addition to the real-time RT-PCR confirmation of the oligonucleotide array data, protein determinations were done for proteins which we could measure: IFN-γ, TNF-α, and IL-10. When comparing monoclonal T cells, cytokine assays confirmed the oligonucleotide array and PCR results. The inversely correlated production of IFN-γ and TNF-α may be explained by differences in transcriptional regulation of their genes and because IFN-γ is differently regulated in γδ T cells and αβ T cells [39, 40]. Although nitrite levels were relatively low compared with levels produced by activated bovine macrophages [28, 29], elevated nitrite in supernatants from clone 61.1G11 versus 61.10.2D7 paralleled the transcript levels detected in the oligonucleotide array and with real-time RT-PCR. This is significant, as it not only indicates protein production but also that the NO synthase produced is functional, as demonstrated by nitrite production. It has recently been shown that human γδ T cells make NO [41], and others have demonstrated NO production by murine CD4+ T cells [42], indicating that the low levels of NO production by the bovine T cell clones are not unusual.

The role of γδ T cells in the immune response A. marginale, a pathogen that infects erythrocytes, is not known. It is interesting that calves under 6 months of age, which have high numbers of WC1+ γδ T cells in peripheral blood, are resistant to Anaplasma infection [43, 44]. It is possible that γδ T cells, which are so prevalent at a young age, play a role in age-associated resistance to anaplasmosis and other hemoparasitic diseases [45].

In summary, this study is the first to compare γδ and αβ T cell clones that respond to the same bacterial antigen. These cells have some functional overlap, but there are striking differences between the two populations. The γδ T cell clones express higher levels of surface receptors and many chemokines not typically associated with αβ T cells, which are usually associated with myeloid or stromal cells. These findings are supported by results of other studies, which demonstrate antigen-presenting capabilities by γδ T cells and the direct response of γδ T cells to LPS [38]. Taken together, these findings strongly support the concept that γδ T cells have cytolytic and cytokine secretory properties commonly associated with αβ T lymphocytes but also have potential to recruit cells via chemokines and perform some functions of professional APC, thereby allowing these “jacks of all trades” to help initiate an adaptive immune response and still respond to antigen. Previous studies also suggest that WC1+ γδ T cell clones used in this study recognize and respond to antigen differently than CD4+ αβ T cell clones specific for the same protein [8]. Further experiments are needed to analyze the functional relevance of the myeloid-associated gene products expressed at higher levels in the γδ T cells. In addition, the mechanisms of antigen recognition by these γδ T cells are not defined and warrant further studies.

Table 1

Primer Sequence for Real-Time RT-PCR

Gene symbolForward (5′–3′)Reverse (5′–3′)Product sizeGenBank accession no.
18S RNACTGAGAAGACGGTCGAACTTGACTTCCGTTAATGATCCTTCCGCAGGT90 bpAY779626
CCL2AGTCACCAGCAGCAAGTGTCCTAATTCTTGGGTTGTGGAGTGAGTGCT165 bpNM174006.2
CCL3TCAAGCCTGGTGTCATCTTCCAGAATGTATTCCTGGACCCAGTCCTCA82 bpAY050252
CCL5AACGCTTTGGAGTTGAGCTAGGGTTGCTTAGGACAAGAGCGAGAAGCA82 bpNM175827.2
CCL8TGCATGTAGGATGGTGAGGTCCTTAGCACACATCCACTTACAGGAGCA94 bpNM174007.1
CCR5ACATGCTGGTTGTCCTCATCCTGAAGCCCAGAATGGGATGGTGATGAT119 bpNM_001011672
CD11aTGAACTCCATGAGGGTGAGGATCAAGTGAAACTGTGCCAAGCACCTAC102 bpBI681282
CD11bAGGAAATCTCGACAGGAGCTCGATTCTGCGTACCCTCAATCGCAAAGA139 bpAJ535320
CD11cTGTCAACCTGAGCTTCTTAGGGCTTTGCTAACGTGCGTCGATAGGACA158 bpBM366605
CD14TCTAGCGCCGTTCAGTGTATGGTTTCCCTTGAGAAACTGTTCCAGGCT81 bpNM_174008.1
CD18AACTGGCAGAAAGCAACATCCAGCTCCACCACGTTCCTGGAATCTTCA133 bpNM175781
CD68TGATGAGAGGCAGCAAGATGGACTGGGCCATAGCTTCAGTTGCAGAAA164 bpCK774183
CXCL1ACATCCAGAGCGTGAAGGTGACAATGAGACACACTTCCTGACCAGTCT93 bpNM175700.1
CXCL2AGAAGCTCTTGGATGGCTGTTCCAAGATGGCCTTAGGAGGTGGTGATT91 bpNM174299.2
CXCL6TTGTGAGAGAGCTGCGTTGTGTGTTCCCTTCCATTCTTCAAGGTGGCT139 bpNM174300.2
CXCL8GGTGCAGAAGGTTGTGCAGGTATTACACCAGACCCACACAGAACATGA176 bpNM_173925.2
CXCR4ACCTGTGGCTAGTGGTGTTTCAGTTTTGGAGTGGGACAGCTTGGAGAT113 bpNM174301.2
FasLCCAGCCAAAGGCATACAGCATCATACCAGGGCAATTCCATAGGTGTCT160 bpAB035802.1
Galectin-3TCGCATTGGGCTTTACTGTACCCATCCGGACCACTGAATGTGCCTTAT97 bpCK849687
GzmAATGACTCAGTCTTTGCTGATCGGGAGAAGCATCTTGCAGCCCTCTGAA121 bpCK950789.1
GranulysinACGCTGTGGTTCTTGTCGGAGAATACAGACCTTTCAGCAGCCTCATCT128 bpCB454206
ICAM-1TGAAGAACTCAACCTGAGCTGCCTTCGACTGCACTGTGAACATGACCT146 bpNM_174348.2
ICAM-3TGAAGAACTCAACCTGAGCTGCCTATTGGTGCCATGGTCCTCTCTTCT169 bpNM_174349.1
IFN-αR1TCCACATGGTATGAGGTTGAGCCAAGCTTGAACGATCCATAGCCCACA157 bpNM_174552.2
IFN-γGAATGGCAGCTCTGAGAAACTGGACGGCCTCGAAAGAGATTCTGACTT171 bpM29867
IL-1αCCACTTCGTGAGGACCAGATGAATTCTTCAGAATCTTCCCACTGGCTG124 bpM37210
IL-1βTCCATGGGAGATGGAAACATCCAGGACGTTTCGAAGATGACAGGCTCT194 bpNM_174093
IL-10aGGTGATGCCACAGGCTGAGAGCTTCTCCCCCAGTGAGTTC69 bpNM_174088.1
IL-18TTCTGCTCTCCAATGCTTTCAGCGTCTGCAGCCATCTTTATGCCTGTG156 bpNM_174091.2
IRF1ATTGTAGTGGACAGCGCAGACAGAATTGTAGTGGACAGCGCAGACAGA141 bpCK960990
Integrin β3TCCCACTTGCTGGTGTTTACCACTTCCATGGTGGTGGAGGCAGAATAA137 bpCK838238
MMRGTGTCACCTGAGGTTATATGTACTTGACAGAAGCAACCAGCTAAGTGTCCTG127 bpBF440340
MSR1TCTGTGAAGTTCGATGCTCGCTCATTTCAGGAGCTGAGCTGCCACTAT174 bpNM_174113.1
PerforinTCCTTTCCAGTTTGGCACAGAGGTTGGACCACGGTCTCCTGAAATTCT178 bpCK771825
Selenoprotein PTTCAGGTCTTCATCACCACCACCAGCAACAGCAGCTACTCAAAGCAGA199 bpAB032826.1
TLR2TGTGAAGAGCGAGTGGTGCAAGTATCAATGGGCTCCAGCAGAATCAGA102 bpNM_174197.2
TLR4ACCTGTATTCAAGGTCTGGCTGGTTTGCACAGTCCCTCCAGGAAAGAT113 bpNM_174198.3
TNF-αCATTGCAGTCTCCTACCAGACCAATCCTCCCTGGTAGATGGGTTCATA121 bpZ14137
XCL1AATCTGTGCTGATCCTCAAGCTGCAAAGTGCTGGAAGGTCACTACCCA147 bpNM175716.2
Gene symbolForward (5′–3′)Reverse (5′–3′)Product sizeGenBank accession no.
18S RNACTGAGAAGACGGTCGAACTTGACTTCCGTTAATGATCCTTCCGCAGGT90 bpAY779626
CCL2AGTCACCAGCAGCAAGTGTCCTAATTCTTGGGTTGTGGAGTGAGTGCT165 bpNM174006.2
CCL3TCAAGCCTGGTGTCATCTTCCAGAATGTATTCCTGGACCCAGTCCTCA82 bpAY050252
CCL5AACGCTTTGGAGTTGAGCTAGGGTTGCTTAGGACAAGAGCGAGAAGCA82 bpNM175827.2
CCL8TGCATGTAGGATGGTGAGGTCCTTAGCACACATCCACTTACAGGAGCA94 bpNM174007.1
CCR5ACATGCTGGTTGTCCTCATCCTGAAGCCCAGAATGGGATGGTGATGAT119 bpNM_001011672
CD11aTGAACTCCATGAGGGTGAGGATCAAGTGAAACTGTGCCAAGCACCTAC102 bpBI681282
CD11bAGGAAATCTCGACAGGAGCTCGATTCTGCGTACCCTCAATCGCAAAGA139 bpAJ535320
CD11cTGTCAACCTGAGCTTCTTAGGGCTTTGCTAACGTGCGTCGATAGGACA158 bpBM366605
CD14TCTAGCGCCGTTCAGTGTATGGTTTCCCTTGAGAAACTGTTCCAGGCT81 bpNM_174008.1
CD18AACTGGCAGAAAGCAACATCCAGCTCCACCACGTTCCTGGAATCTTCA133 bpNM175781
CD68TGATGAGAGGCAGCAAGATGGACTGGGCCATAGCTTCAGTTGCAGAAA164 bpCK774183
CXCL1ACATCCAGAGCGTGAAGGTGACAATGAGACACACTTCCTGACCAGTCT93 bpNM175700.1
CXCL2AGAAGCTCTTGGATGGCTGTTCCAAGATGGCCTTAGGAGGTGGTGATT91 bpNM174299.2
CXCL6TTGTGAGAGAGCTGCGTTGTGTGTTCCCTTCCATTCTTCAAGGTGGCT139 bpNM174300.2
CXCL8GGTGCAGAAGGTTGTGCAGGTATTACACCAGACCCACACAGAACATGA176 bpNM_173925.2
CXCR4ACCTGTGGCTAGTGGTGTTTCAGTTTTGGAGTGGGACAGCTTGGAGAT113 bpNM174301.2
FasLCCAGCCAAAGGCATACAGCATCATACCAGGGCAATTCCATAGGTGTCT160 bpAB035802.1
Galectin-3TCGCATTGGGCTTTACTGTACCCATCCGGACCACTGAATGTGCCTTAT97 bpCK849687
GzmAATGACTCAGTCTTTGCTGATCGGGAGAAGCATCTTGCAGCCCTCTGAA121 bpCK950789.1
GranulysinACGCTGTGGTTCTTGTCGGAGAATACAGACCTTTCAGCAGCCTCATCT128 bpCB454206
ICAM-1TGAAGAACTCAACCTGAGCTGCCTTCGACTGCACTGTGAACATGACCT146 bpNM_174348.2
ICAM-3TGAAGAACTCAACCTGAGCTGCCTATTGGTGCCATGGTCCTCTCTTCT169 bpNM_174349.1
IFN-αR1TCCACATGGTATGAGGTTGAGCCAAGCTTGAACGATCCATAGCCCACA157 bpNM_174552.2
IFN-γGAATGGCAGCTCTGAGAAACTGGACGGCCTCGAAAGAGATTCTGACTT171 bpM29867
IL-1αCCACTTCGTGAGGACCAGATGAATTCTTCAGAATCTTCCCACTGGCTG124 bpM37210
IL-1βTCCATGGGAGATGGAAACATCCAGGACGTTTCGAAGATGACAGGCTCT194 bpNM_174093
IL-10aGGTGATGCCACAGGCTGAGAGCTTCTCCCCCAGTGAGTTC69 bpNM_174088.1
IL-18TTCTGCTCTCCAATGCTTTCAGCGTCTGCAGCCATCTTTATGCCTGTG156 bpNM_174091.2
IRF1ATTGTAGTGGACAGCGCAGACAGAATTGTAGTGGACAGCGCAGACAGA141 bpCK960990
Integrin β3TCCCACTTGCTGGTGTTTACCACTTCCATGGTGGTGGAGGCAGAATAA137 bpCK838238
MMRGTGTCACCTGAGGTTATATGTACTTGACAGAAGCAACCAGCTAAGTGTCCTG127 bpBF440340
MSR1TCTGTGAAGTTCGATGCTCGCTCATTTCAGGAGCTGAGCTGCCACTAT174 bpNM_174113.1
PerforinTCCTTTCCAGTTTGGCACAGAGGTTGGACCACGGTCTCCTGAAATTCT178 bpCK771825
Selenoprotein PTTCAGGTCTTCATCACCACCACCAGCAACAGCAGCTACTCAAAGCAGA199 bpAB032826.1
TLR2TGTGAAGAGCGAGTGGTGCAAGTATCAATGGGCTCCAGCAGAATCAGA102 bpNM_174197.2
TLR4ACCTGTATTCAAGGTCTGGCTGGTTTGCACAGTCCCTCCAGGAAAGAT113 bpNM_174198.3
TNF-αCATTGCAGTCTCCTACCAGACCAATCCTCCCTGGTAGATGGGTTCATA121 bpZ14137
XCL1AATCTGTGCTGATCCTCAAGCTGCAAAGTGCTGGAAGGTCACTACCCA147 bpNM175716.2
Primer sequences were based on a previously published, real-time PCR protocol using TaqMan chemistry [24]. GzmA, Granzyme A; IRF1, IFN response factor 1; MMR, macrophage mannose receptor; MSR1, macrophage scavenger receptor 1.
Table 1

Primer Sequence for Real-Time RT-PCR

Gene symbolForward (5′–3′)Reverse (5′–3′)Product sizeGenBank accession no.
18S RNACTGAGAAGACGGTCGAACTTGACTTCCGTTAATGATCCTTCCGCAGGT90 bpAY779626
CCL2AGTCACCAGCAGCAAGTGTCCTAATTCTTGGGTTGTGGAGTGAGTGCT165 bpNM174006.2
CCL3TCAAGCCTGGTGTCATCTTCCAGAATGTATTCCTGGACCCAGTCCTCA82 bpAY050252
CCL5AACGCTTTGGAGTTGAGCTAGGGTTGCTTAGGACAAGAGCGAGAAGCA82 bpNM175827.2
CCL8TGCATGTAGGATGGTGAGGTCCTTAGCACACATCCACTTACAGGAGCA94 bpNM174007.1
CCR5ACATGCTGGTTGTCCTCATCCTGAAGCCCAGAATGGGATGGTGATGAT119 bpNM_001011672
CD11aTGAACTCCATGAGGGTGAGGATCAAGTGAAACTGTGCCAAGCACCTAC102 bpBI681282
CD11bAGGAAATCTCGACAGGAGCTCGATTCTGCGTACCCTCAATCGCAAAGA139 bpAJ535320
CD11cTGTCAACCTGAGCTTCTTAGGGCTTTGCTAACGTGCGTCGATAGGACA158 bpBM366605
CD14TCTAGCGCCGTTCAGTGTATGGTTTCCCTTGAGAAACTGTTCCAGGCT81 bpNM_174008.1
CD18AACTGGCAGAAAGCAACATCCAGCTCCACCACGTTCCTGGAATCTTCA133 bpNM175781
CD68TGATGAGAGGCAGCAAGATGGACTGGGCCATAGCTTCAGTTGCAGAAA164 bpCK774183
CXCL1ACATCCAGAGCGTGAAGGTGACAATGAGACACACTTCCTGACCAGTCT93 bpNM175700.1
CXCL2AGAAGCTCTTGGATGGCTGTTCCAAGATGGCCTTAGGAGGTGGTGATT91 bpNM174299.2
CXCL6TTGTGAGAGAGCTGCGTTGTGTGTTCCCTTCCATTCTTCAAGGTGGCT139 bpNM174300.2
CXCL8GGTGCAGAAGGTTGTGCAGGTATTACACCAGACCCACACAGAACATGA176 bpNM_173925.2
CXCR4ACCTGTGGCTAGTGGTGTTTCAGTTTTGGAGTGGGACAGCTTGGAGAT113 bpNM174301.2
FasLCCAGCCAAAGGCATACAGCATCATACCAGGGCAATTCCATAGGTGTCT160 bpAB035802.1
Galectin-3TCGCATTGGGCTTTACTGTACCCATCCGGACCACTGAATGTGCCTTAT97 bpCK849687
GzmAATGACTCAGTCTTTGCTGATCGGGAGAAGCATCTTGCAGCCCTCTGAA121 bpCK950789.1
GranulysinACGCTGTGGTTCTTGTCGGAGAATACAGACCTTTCAGCAGCCTCATCT128 bpCB454206
ICAM-1TGAAGAACTCAACCTGAGCTGCCTTCGACTGCACTGTGAACATGACCT146 bpNM_174348.2
ICAM-3TGAAGAACTCAACCTGAGCTGCCTATTGGTGCCATGGTCCTCTCTTCT169 bpNM_174349.1
IFN-αR1TCCACATGGTATGAGGTTGAGCCAAGCTTGAACGATCCATAGCCCACA157 bpNM_174552.2
IFN-γGAATGGCAGCTCTGAGAAACTGGACGGCCTCGAAAGAGATTCTGACTT171 bpM29867
IL-1αCCACTTCGTGAGGACCAGATGAATTCTTCAGAATCTTCCCACTGGCTG124 bpM37210
IL-1βTCCATGGGAGATGGAAACATCCAGGACGTTTCGAAGATGACAGGCTCT194 bpNM_174093
IL-10aGGTGATGCCACAGGCTGAGAGCTTCTCCCCCAGTGAGTTC69 bpNM_174088.1
IL-18TTCTGCTCTCCAATGCTTTCAGCGTCTGCAGCCATCTTTATGCCTGTG156 bpNM_174091.2
IRF1ATTGTAGTGGACAGCGCAGACAGAATTGTAGTGGACAGCGCAGACAGA141 bpCK960990
Integrin β3TCCCACTTGCTGGTGTTTACCACTTCCATGGTGGTGGAGGCAGAATAA137 bpCK838238
MMRGTGTCACCTGAGGTTATATGTACTTGACAGAAGCAACCAGCTAAGTGTCCTG127 bpBF440340
MSR1TCTGTGAAGTTCGATGCTCGCTCATTTCAGGAGCTGAGCTGCCACTAT174 bpNM_174113.1
PerforinTCCTTTCCAGTTTGGCACAGAGGTTGGACCACGGTCTCCTGAAATTCT178 bpCK771825
Selenoprotein PTTCAGGTCTTCATCACCACCACCAGCAACAGCAGCTACTCAAAGCAGA199 bpAB032826.1
TLR2TGTGAAGAGCGAGTGGTGCAAGTATCAATGGGCTCCAGCAGAATCAGA102 bpNM_174197.2
TLR4ACCTGTATTCAAGGTCTGGCTGGTTTGCACAGTCCCTCCAGGAAAGAT113 bpNM_174198.3
TNF-αCATTGCAGTCTCCTACCAGACCAATCCTCCCTGGTAGATGGGTTCATA121 bpZ14137
XCL1AATCTGTGCTGATCCTCAAGCTGCAAAGTGCTGGAAGGTCACTACCCA147 bpNM175716.2
Gene symbolForward (5′–3′)Reverse (5′–3′)Product sizeGenBank accession no.
18S RNACTGAGAAGACGGTCGAACTTGACTTCCGTTAATGATCCTTCCGCAGGT90 bpAY779626
CCL2AGTCACCAGCAGCAAGTGTCCTAATTCTTGGGTTGTGGAGTGAGTGCT165 bpNM174006.2
CCL3TCAAGCCTGGTGTCATCTTCCAGAATGTATTCCTGGACCCAGTCCTCA82 bpAY050252
CCL5AACGCTTTGGAGTTGAGCTAGGGTTGCTTAGGACAAGAGCGAGAAGCA82 bpNM175827.2
CCL8TGCATGTAGGATGGTGAGGTCCTTAGCACACATCCACTTACAGGAGCA94 bpNM174007.1
CCR5ACATGCTGGTTGTCCTCATCCTGAAGCCCAGAATGGGATGGTGATGAT119 bpNM_001011672
CD11aTGAACTCCATGAGGGTGAGGATCAAGTGAAACTGTGCCAAGCACCTAC102 bpBI681282
CD11bAGGAAATCTCGACAGGAGCTCGATTCTGCGTACCCTCAATCGCAAAGA139 bpAJ535320
CD11cTGTCAACCTGAGCTTCTTAGGGCTTTGCTAACGTGCGTCGATAGGACA158 bpBM366605
CD14TCTAGCGCCGTTCAGTGTATGGTTTCCCTTGAGAAACTGTTCCAGGCT81 bpNM_174008.1
CD18AACTGGCAGAAAGCAACATCCAGCTCCACCACGTTCCTGGAATCTTCA133 bpNM175781
CD68TGATGAGAGGCAGCAAGATGGACTGGGCCATAGCTTCAGTTGCAGAAA164 bpCK774183
CXCL1ACATCCAGAGCGTGAAGGTGACAATGAGACACACTTCCTGACCAGTCT93 bpNM175700.1
CXCL2AGAAGCTCTTGGATGGCTGTTCCAAGATGGCCTTAGGAGGTGGTGATT91 bpNM174299.2
CXCL6TTGTGAGAGAGCTGCGTTGTGTGTTCCCTTCCATTCTTCAAGGTGGCT139 bpNM174300.2
CXCL8GGTGCAGAAGGTTGTGCAGGTATTACACCAGACCCACACAGAACATGA176 bpNM_173925.2
CXCR4ACCTGTGGCTAGTGGTGTTTCAGTTTTGGAGTGGGACAGCTTGGAGAT113 bpNM174301.2
FasLCCAGCCAAAGGCATACAGCATCATACCAGGGCAATTCCATAGGTGTCT160 bpAB035802.1
Galectin-3TCGCATTGGGCTTTACTGTACCCATCCGGACCACTGAATGTGCCTTAT97 bpCK849687
GzmAATGACTCAGTCTTTGCTGATCGGGAGAAGCATCTTGCAGCCCTCTGAA121 bpCK950789.1
GranulysinACGCTGTGGTTCTTGTCGGAGAATACAGACCTTTCAGCAGCCTCATCT128 bpCB454206
ICAM-1TGAAGAACTCAACCTGAGCTGCCTTCGACTGCACTGTGAACATGACCT146 bpNM_174348.2
ICAM-3TGAAGAACTCAACCTGAGCTGCCTATTGGTGCCATGGTCCTCTCTTCT169 bpNM_174349.1
IFN-αR1TCCACATGGTATGAGGTTGAGCCAAGCTTGAACGATCCATAGCCCACA157 bpNM_174552.2
IFN-γGAATGGCAGCTCTGAGAAACTGGACGGCCTCGAAAGAGATTCTGACTT171 bpM29867
IL-1αCCACTTCGTGAGGACCAGATGAATTCTTCAGAATCTTCCCACTGGCTG124 bpM37210
IL-1βTCCATGGGAGATGGAAACATCCAGGACGTTTCGAAGATGACAGGCTCT194 bpNM_174093
IL-10aGGTGATGCCACAGGCTGAGAGCTTCTCCCCCAGTGAGTTC69 bpNM_174088.1
IL-18TTCTGCTCTCCAATGCTTTCAGCGTCTGCAGCCATCTTTATGCCTGTG156 bpNM_174091.2
IRF1ATTGTAGTGGACAGCGCAGACAGAATTGTAGTGGACAGCGCAGACAGA141 bpCK960990
Integrin β3TCCCACTTGCTGGTGTTTACCACTTCCATGGTGGTGGAGGCAGAATAA137 bpCK838238
MMRGTGTCACCTGAGGTTATATGTACTTGACAGAAGCAACCAGCTAAGTGTCCTG127 bpBF440340
MSR1TCTGTGAAGTTCGATGCTCGCTCATTTCAGGAGCTGAGCTGCCACTAT174 bpNM_174113.1
PerforinTCCTTTCCAGTTTGGCACAGAGGTTGGACCACGGTCTCCTGAAATTCT178 bpCK771825
Selenoprotein PTTCAGGTCTTCATCACCACCACCAGCAACAGCAGCTACTCAAAGCAGA199 bpAB032826.1
TLR2TGTGAAGAGCGAGTGGTGCAAGTATCAATGGGCTCCAGCAGAATCAGA102 bpNM_174197.2
TLR4ACCTGTATTCAAGGTCTGGCTGGTTTGCACAGTCCCTCCAGGAAAGAT113 bpNM_174198.3
TNF-αCATTGCAGTCTCCTACCAGACCAATCCTCCCTGGTAGATGGGTTCATA121 bpZ14137
XCL1AATCTGTGCTGATCCTCAAGCTGCAAAGTGCTGGAAGGTCACTACCCA147 bpNM175716.2
Primer sequences were based on a previously published, real-time PCR protocol using TaqMan chemistry [24]. GzmA, Granzyme A; IRF1, IFN response factor 1; MMR, macrophage mannose receptor; MSR1, macrophage scavenger receptor 1.
Table 2

Proliferative Responses of T Cell Clones to A. marginale Antigens

AntigenProliferation (SI)
αβ T cell clonesγδ T cell clones
61.10.2D761.3H561.1G1161.3G3
A. marginale52.4a6.3101.410.7
MSP2NDb5.56.811.4
URBC1.30.71.70.7
P10192.40.79.81.4
P120.41.41.12.4
AntigenProliferation (SI)
αβ T cell clonesγδ T cell clones
61.10.2D761.3H561.1G1161.3G3
A. marginale52.4a6.3101.410.7
MSP2NDb5.56.811.4
URBC1.30.71.70.7
P10192.40.79.81.4
P120.41.41.12.4
a

T cell clones (3×104 cells/well) were cultured in duplicate wells for 3 days with 2 × 105 irradiated, autologous PBMC as a source of APC and antigen, radiolabeled overnight, and harvested. Results are presented as the SI, calculated as the mean cpm of cells cultured with 10 μg/ml antigen/mean cpm of cells cultured with medium. Statistically significant results are in bold.

b

Not determined in the assay performed 1 week prior to Con A and IL-2 stimulation. In a previous experiment, the SI of this clone to MSP2 compared with medium was 58.9.

Table 2

Proliferative Responses of T Cell Clones to A. marginale Antigens

AntigenProliferation (SI)
αβ T cell clonesγδ T cell clones
61.10.2D761.3H561.1G1161.3G3
A. marginale52.4a6.3101.410.7
MSP2NDb5.56.811.4
URBC1.30.71.70.7
P10192.40.79.81.4
P120.41.41.12.4
AntigenProliferation (SI)
αβ T cell clonesγδ T cell clones
61.10.2D761.3H561.1G1161.3G3
A. marginale52.4a6.3101.410.7
MSP2NDb5.56.811.4
URBC1.30.71.70.7
P10192.40.79.81.4
P120.41.41.12.4
a

T cell clones (3×104 cells/well) were cultured in duplicate wells for 3 days with 2 × 105 irradiated, autologous PBMC as a source of APC and antigen, radiolabeled overnight, and harvested. Results are presented as the SI, calculated as the mean cpm of cells cultured with 10 μg/ml antigen/mean cpm of cells cultured with medium. Statistically significant results are in bold.

b

Not determined in the assay performed 1 week prior to Con A and IL-2 stimulation. In a previous experiment, the SI of this clone to MSP2 compared with medium was 58.9.

Figure 1

Flow cytometric analysis of T cell clones; γδ T cell clones 61.1G11 and 61.3G3 are presented (a and b, respectively). αβ T cell clones 61.10.2D7 and 61.3H5 are presented (c and d, respectively). Control staining without primary antibody is represented by the solid silver in the histograms. Staining for CD4 is represented by the open gray histogram, and staining for the γδ TCR is represented by the open black histograms.

Table 3

Immune Function-Related Genes Differentially Regulated in the Oligonucleotide Array When Comparing γδT Cell Clone 61.1G11 and αβT Cell Clone 61.10.2D7

Gene IDGene nameDescriptionAccessionRatioa
Genes with higher transcript levels in γδ T cell clone 61.1G11
TCR-associated genes
Bt.28004.2.S1_a_atT cell receptor δ chain, V, D, and J regions, BTDV2T cell receptorD13656.1675
Bt.28004.2.A1_a_atT cell receptor δ chain, V, D, and J regions, BTDV2T cell receptorD13656.112.1
Bt.28007.1.A1_s_atT cell receptor δ chain, V, D, and J regions, BTDV6T cell receptorCK96920690.5
Bt.28732.1.S1_atT cell receptor δ chain, a part of V, D, J, and C regionsT cell receptorD90419.1776
Bt.28732.1.S1_s_atT cell receptor δ chain, a part of V, D, J, and C regionsT cell receptorD90419.1256
Bt.29691.1.S1_atT cell receptor δ chain variable region, BVd1.16T cell receptorU73383.12.6
Bt.29689.1.S1_s_atT cell receptor δ chain variable region, BVd1.21T cell receptorCK834180256
Bt.29695.1.A1_s_atT cell receptor γ chain variable region BVG3.1T cell receptorBE5884807.0
Bt.29695.1.A1_atT cell receptor γ chain variable region BVG3.1T cell receptorBE5884806.1
Bt.29695.1.S1_atT cell receptor γ chain variable region BVG3.1T cell receptorU73186.117.1
Bt.29694.1.S1_atT cell receptor γ chain variable region BVG3.2T cell receptorU73187.117.1
Bt.29693.1.S1_atT cell receptor γ chain variable region BVG7T cell receptorCK83617673.5
Bt.29693.1.A1_atT cell receptor γ chain variable region BVG7T cell receptorCK8361763.7
Surface molecules and receptors
Bt.7027.1.S1_atMHC class I-like family A1 (MHCLA1)MHC class IAF317556.13.3
Bt.1007.1.S1_atMHC class II DM β-chainMHC class IICK7730782.1
Bt.2227.1.S1_atHLA class II histocompatibility antigen, DZ α chainMHC class IIBI8491715.7
Bt.4482.1.S1_atMacrophage scavenger receptor type 1Binding and phagocytosis of bacteriaNM_174113.190.5
Bt.4482.2.S1_a_atMacrophage scavenger receptor type 1Binding and phagocytosis of bacteriaX51689.13.7
Bt.4482.2.S1_atMacrophage scavenger receptor type 1Binding and phagocytosis of bacteriaX51689.12.3
Bt.20836.1.S1_atMacrophage mannose receptor precursorBinds high mannose structures of pathogensCK94601618.4
Bt.23089.1.S1_atMacrophage mannose receptor precursorBinds high mannose structures of pathogensBF4403408.6
Bt.6850.1.S1_a_atCD3 δComponent of CD3X53269.12.1
Bt.2573.1.S1_atCD9Mediates platelet aggregation and activationNM_173900.27.5
Bt.248.1.S1_atCD38NAD glycohydrolase, augments B cell proliferationNM_175798.24.9
Bt.13496.2.S1_aCD63Lysosomal membrane proteinCK8495123.5
Bt.2334.1.S1_atMacrophage antigen CD68Macrosialin, macrophage-specific markerCK7741838.6
Bt.20940.1.S1_atT cell activation antigen (CD96 antigen)Expressed on activated T cellsCK7702912.8
Bt.4285.1.S1_atCD14Myeloid membrane protein (macrophage-specific)NM_174008.18.0
Bt.9030.1.S1_atToll-like receptor 4 (TLR4)Responds to LPS in conjunction with CD14NM_174198.33.7
Bt.8140.1.S1_atFc fragment of IgE, high-affinity IHigh-affinity receptor for IgENM_174537.14.9
Bt.284.1.S1_atFc fragment of IgG, high-affinity Ia (CD64)High-affinity receptor for IgGNM_174538.22.1
Bt.28015.1.S1_atFc-γ 2 receptorInhibits stimulationZ37506.14.0
Bt.4110.1.S1_atHistamine H1 receptorHistamine H1 receptorNM_174083.25.7
Bt.3843.1.S1_atImmunoglobulin J chainComponent of immunoglobulinNM_175773.19.2
Bt.13039.1.S1_atIntegrin, β 3 (CD61)Associates with glycoprotein IIb/IIIa or CD51CK8382383.3
Bt.21219.1.S1_atIntegrin α-E chain (CD103)Associates with β7 and binds E-cadherin in the gutCK9809752.6
Bt.9483.1.S1_atIntegrin α-D precursor (CD11d)Binds CD50; expressed on leukocytesBM3648732.3
Bt.27978.1.S1_atLeukocyte integrin α-M chain (CD11b)Binds ICAM-1, complement 3, fibrinogen (Mac1)AJ535320.16.5
Bt.1416.1.S1_atGalectin-3Galactose-specific lectin abundant on macrophages (Mac2)CK8496875.3
Bt.11241.1.S1_atE-cadherinA ligand for integrin α-E/β7CK9481765.3
Bt.5372.1.S1_atIntercellular adhesion molecule 1 (CD54)Binds LFA-1, Mac1NM_174348.22.5
Bt.4293.1.S1_atIntercellular adhesion molecule 3T cell molecule that binds CD209 on dendritic cellsNM_174349.13.0
Bt.10077.1.S3_atInterferon responsive factor 1Regulates response to IFN-γCK9609904.0
Bt.10077.1.S2_atInterferon responsive factor 1Regulates response to IFN-γCK9506853.0
Bt.5768.2.S1_atInterferon regulatory factor 7Role in virus-activated transcription of IFN-α genesBF7745132.0
Bt.4557.1.S1_atInterferon, α; receptorReceptor for IFN-αNM_174552.22.8
Bt.23148.1.S1_atInterleukin 11 receptor, αReceptor for IL-11CK9464082.3
Bt.7213.1.S1_atInterleukin 12 receptor, β2Receptor for IL-12 associated with IFN productionNM_174645.22.6
Bt.13851.1.S1_atInterleukin-13 receptor α-1 chain precursorReceptor for IL-13CK9664494.6
Bt.11174.1.S1_atKIR2DL1 Killer cell immunoglobulin-like receptorInhibits NK cell cytotoxicity on binding MHC I (CD158a)NM_174740.29.2
Bt.24545.1.S1_atNatural killer cell receptor group D variant 2Activating member of the NKG2 receptorsCK9520802.6
Bt.28588.2.A1_a_atNatural killer receptor 2B4 (CD244)Modulates other receptor-ligand interactions to activateCK9714832.6
Secreted products
Bt.8144.1.S1_atChemokine (C motif) ligand 1 (XCL1)Lymphocyte trafficking and development (Lymphoactin)NM_175716.26.5
Bt.2408.1.S1_s_atChemokine (C-C motif) ligand 2 (CCL2)Monocyte-chemoattractant protein-1NM_174006.264.0
Bt.2408.1.S1_atChemokine (C-C motif) ligand 2 (CCL2)Monocyte-chemoattractant protein-1NM_174006.226.0
Bt.154.1.S1_atChemokine (C-C motif) ligand 8 (CCL8)Monocyte-chemoattractant protein-2NM_174007.12.3
Bt.611.1.S2_atChemokine (C-X-C motif) ligand 1 (CXCL1)Neutrophil chemoattractant (GRO-α)NM_175700.15.3
Bt.611.1.S1_atChemokine (C-X-C motif) ligand 1 (CXCL1)Neutrophil chemoattractant (GRO-α)U95813.17.5
Bt.611.1.S1_x_atChemokine (C-X-C motif) ligand 1 (CXCL1)Neutrophil chemoattractant (GRO-α)U95813.17.0
Bt.610.1.A1_atChemokine (C-X-C motif) ligand 2 (CXCL2)Neutrophil chemoattractant (GRO-β)NM_174299.23.7
Bt.23093.1.S1_atChemokine (C-X-C motif) ligand 3 (CXCL3)Neutrophil chemoattractant (GRO-γ)CF9299895.7
Bt.7165.1.S1_atChemokine (C-X-C motif) ligand 6 (CXCL6)Neutrophil chemoattractant (GCP-2)NM_174300.22.3
Bt.8957.1.S1_atChemokine (C-X-C motif) receptor 4 (CXCR4)Receptor for SDF-1 chemokineNM_174301.23.3
Bt.191.1.S2_atInterleukin 1, αT cell and macrophage activationNM_174092.12.3
Bt.191.1.S1_atInterleukin-1, αT cell and macrophage activationM36182.12.5
Bt.4856.1.S2_atInterleukin 1, βT cell and macrophage activationNM_174093.13.0
Bt.4856.1.S1_atInterleukin 1, βT cell and macrophage activationM35589.12.6
Bt.423.1.S1_atInterleukin 4B cell activationNM_173921.23.0
Bt.5.1.S1_atInterleukin 5Eosinophil growth, differentiationNM_173922.110.6
Bt.12751.1.S1_atInterleukin 7Growth of pre-B cells and pre-T cellsNM_173924.22.0
Bt.155.1.S1_atInterleukin 8 (CXCL8)Lymphocyte-derived neutrophil-activating factorNM_173925.22.0
Bt.4723.1.S1_atInterleukin 10Potent suppressant of macrophage functionNM_174088.12.8
Bt.12928.1.S1_atInterleukin 13B cell growth, inhibits macrophage inflammatory cytokinesNM_174089.122.6
Bt.19162.1.A1_atInterleukin 13B cell growth, inhibits macrophage inflammatory cytokinesCB45626118.4
Bt.234.1.S1_atInterleukin 18Induces IFN-γ production; favors TH1NM_174091.22.8
Bt.26527.1.S1_a_atInterleukin-16 precursorChemoattractant for CD4 T cells, monocytes, eosinophilsCK8482363.0
Bt.12756.1.S1_atTumor necrosis factor-αLocal inflammation, endothelial activationNM_173966.13.3
Bt.9286.1.S1_atLPS-induced TNF-α factorLocal inflammation, endothelial activationCK9803422.0
Bt.29672.1.S1_atGranzyme A precursor (gzmA gene)Induces perforin-mediated apoptosisCK9507892.5
Bt.146.1.S1_atNeutrophil β-defensin 4Suppress cytokine production and NK cell activityAF014107.116.0
Bt.13125.1.S1Neutrophil β-defensin 4Suppress cytokine production and NK cell activityBM1063726.1
Bt.21431.2.S1_atLymphotoxin βStimulates lymph node developmentCB4287143.7
Bt.21431.3.S1_atLymphotoxin βStimulates lymph node developmentBE6680042.3
Bt.21431.1.S1_atLymphotoxin βStimulates lymph node developmentCK9481332.0
Bt.27067.1.A1_atLymphotoxin α precursorStimulates killing, endothelial activationCK7741129.9
Bt.24345.1.S1_atComplement component 2 precursorCleaves C3 and C5CK7723129.2
Bt.24345.2.S1_atComplement component 2 precursorCleaves C3 and C5BE4876144.9
Bt.8803.1.A1_atComplement C1r component precursorCleaves C1s to active proteaseCK9500264.3
Cytoplasmic molecules
Bt.142.1.S1_atNeutrophil cytosolic factor 1Part of NADPH oxidase; produces superoxideNM_174119.213.0
Bt.143.1.S1_atNeutrophil cytosolic factor 2Part of NADPH oxidase; produces superoxideNM_174120.212.1
Bt.7625.1.S1_a_atNeutrophil cytosolic factor 4Part of NADPH oxidase; produces superoxideCK7759622.5
Bt.23126.2.S1_atNitric oxide synthase 2AInducible nitric oxide synthaseAW6541108.0
Bt.23126.1.S1_atNitric oxide synthase 2AInducible nitric oxide synthaseCK8325074.3
Bt.8479.1.A1_atNO synthaseInducible nitric oxide synthaseBF0400873.0
Bt.8947.1.S1_atLegumainCysteine endoprotease that hydrolyzes asparaginyl bondsNM_174101.23.7
Bt.15758.1.S1_atProstaglandin-endoperoxide synthase 2Key enzyme in prostaglandin biosynthesis (COX2)NM_174445.22.6
Bt.13273.1.S1_atSuppressor of cytokine signaling 2Regulator of cytokine signal transductionNM_177523.22.5
Bt.22739.2.S1_atSuppressor of cytokine signaling 4Regulator of cytokine signal transductionCB4226582.0
Bt.23278.1.S1_atAllograft inflammatory factor 1Augments production of IL-6, IL-10, and IL-12NM_173985.26.1
Bt.12304.1.S1_atInterferon-stimulated protein, 15 kDaInduces B cell proliferation and T cell cytokine productionNM_174366.14.6
Bt.9308.1.S1_atLymphocyte phosphatase-associated phosphoproteinCytoplasmic tyrosine kinase necessary for TCR signalingBM2521173.3
Bt.26983.1.S1_atInterleukin-1β converting enzyme β isozymeCleaves and activates the inactive precursor of IL-1CK7767884.9
Bt.16623.1.A1_atNuclear factor of activated T cells 5, isoform cUp-regulates members of the TNF familyCB4221272.6
Bt.24855.2.S1_atTumor necrosis factor ligand superfamily member 13BInvolved in B cell proliferationBE7534402.5
Bt.18959.1.A1_atLymphocyte activation gene-3 (LAG-3/CD223)Binds to MHC class II; may be involved in down-regulationCB4522782.6
Bt.10855.1.S1_atRegulator of G-protein signaling 2 (RGS2)Inhibits G-protein signaling including chemokine signalsCB1691174.9
Bt.4781.1.S1_atA disintegrin and metalloproteinase domain10 (ADAM10)Cleaves L1 adhesion molecule to induce cell migrationNM_174496.22.1
Genes with higher transcript levels in αβ T cell clone 61.10.2D7
TCR-associated genes
Bt.28000.1.S1_atT-cell receptor γ chain V and J regionsT cell receptorBM362209−11.3b
Bt.4289.1.S1_atBovine T cell receptor α chain, and constant regionsT cell receptorCK960422−6.0
Bt.29765.1.S1_atT cell receptor β chain V-regionT cell receptorCK836454−337
Bt.1978.1.S1_a_atT cell receptor, β clusterT cell receptorCB172009−2.1
Bt.1978.1.S1_atT cell receptor, β clusterT cell receptorCB172009−2.6
Bt.1978.2.S1_x_atT cell receptor, β clusterT cell receptorCK775366−2.0
Bt.28013.1.S1_atBTGT1 mRNA for T cell receptor γ chainT cell receptorBE752633−27.9
Surface molecules and receptors
Bt.13087.1.S1_atCD6Binds CD166AB042274.1−4.3
Bt.48.1.S1_a_atCD28Binds CD80 and CD86NM_181004.1−24.3
Bt.48.3.S1_a_atCD28 isoform 2Binds CD80 and CD86AY064487.1−18.4
Bt.4497.1.S1_atCD5 antigen (p56–62)Expressed at high density on mature T cellsNM_173899.2−27.9
Bt.29099.1.S1_atT lymphocyte activation antigen CD80 precursorCostimulator, Ligand for CD28 and CTLA4CK955216−2.1
Bt.24707.1.S1_atCD86 mRNACostimulator, Ligand for CD28 and CTLA4AY533858.1−2.0
Bt.13097.1.S1_atCD86Costimulator, Ligand for CD28 and CTLA4AJ291475.1−2.5
Bt.3841.1.S1_atCD83 antigenDendritic cell-associated moleculeCK773094−8.0
Bt.3841.2.S1_atCD83 antigenDendritic cell-associated moleculeBE755445−9.9
Bt.10954.1.S1_atT cell surface antigen CD2 precursorBinds CD58 and activates T cellsCK774743−68.6
Bt.10954.2.S1_a_atT cell surface antigen CD2 precursorBinds CD58 and activates T cellsAW658942−73.5
Bt.10954.2.S1_atT cell surface antigen CD2 precursorBinds CD58 and activates T cellsAW658942−14.9
Bt.27979.1.S1_atCD4Coreceptor for MHC class IIAJ535319.1−9.9
Bt.79.1.S1_atCytotoxic T-lymphocyte-associated protein 4Negative regulator of T cell activationNM_174297.1−4.3
Bt.11174.3.S1KIR2DL1 Killer cell immunoglobulin-like receptorInhibits NK cell cytotoxicity on binding MHC IAF490400.1−4.9
Bt.22948.1.S1KIR3DL1 Killer cell immunoglobulin-like receptorInhibits NK cell cytotoxicity on binding MHC INM_181451.1−5.3
Bt.11174.2.S1KIR2DL1 NK receptor KIR3DL1-like protein pseudogeneInhibits NK cell cytotoxicity on binding MHC IAY075103.1−3.5
Bt.8547.1.S1_atSignaling lymphocytic activation molecule (CD150)Promotes T cell activation and IFN-γ productionNM_174184.2−3.5
Bt.22692.1.A1_atInterleukin-6 receptor precursor (CD126)IL-6 receptor αCK774531−5.7
Bt.12301.1.S1_atProstaglandin E receptor 2Decreased proliferation and cytokine releaseNM_174588.2−2.0
Bt.22749.1.A1_atProstaglandin F2 receptor negative regulatorAssociates with CD9 and CD81BP107094−2.1
Bt.22634.1.S1_atProstaglandin F2-α receptor regulatory proteinAssociates with CD9 and CD81BP109430−3.5
Bt.22634.2.A1_atProstaglandin F2-α receptor regulatory proteinAssociates with CD9 and CD81CB536196−3.0
Bt.22634.3.S1_atProstaglandin F2 receptor negative regulator precursorAssociates with CD9 and CD81CK946156−2.5
Bt.352.2.S1_atProstaglandin F2α receptor isoform-αReceptor for PGF2αAB083784.1−22.6
Bt.24531.1.S1_atInterleukin-4 receptor α chain precursor (CD124)IL-4 receptorAV666299−2.5
Bt.18375.1.S1_atTNF ligand superfamily member 5 (CD40L)Inducer of B cell proliferation and activationCB443472−97.0
Bt.49.1.S1_atTNF ligand superfamily member 5 (CD40L)Inducer of B cell proliferation and activationNM_174624.2−181
Bt.13148.1.S1_atVascular endothelial growth factor (VEGF)-receptor-1, fit-receptor proteinReceptor for VEGF with protein kinase activityX94263.1−3.3
Secreted products
Bt.523.1.S1_atInterleukin 12 p40Induces IFN-γ productionNM_174356.1−13.0
Bt.538.1.S1_atInterleukin 3Synergistic action in early hematopoiesisNM_173920.2−42.2
Bt.3686.1.S1_atInterleukin 6T cell and B cell growth and differentiationNM_173923.2−3.3
Bt.4336.1.S1_atComplement factor D precursorPlasma serine protease cleaves B when bound to C3bCK771764−4.6
Bt.4138.2.S1_atVascular endothelial growth factor (VEGF)Growth factor involved in angiogenesisCB450531−3.7
Bt.4138.1.S1_a_atVascular endothelial growth factor (VEGF)Growth factor involved in angiogenesisNM_174216.1−4.0
Cytoplasmic molecules
Bt.5154.1.S1_atHeat shock 70 kD protein 1Inducible isoforms of Hsp70NM_174550.1−2.0
Bt.5154.1.S1_sHeat shock 70 kD protein 1Inducible isoforms of Hsp70NM_174550.1−2.0
Bt.12241.1.S1_atLymphocyte-specific G protein-coupled receptor EBI1G-protein associated with CCR7CK770049−5.3
Gene IDGene nameDescriptionAccessionRatioa
Genes with higher transcript levels in γδ T cell clone 61.1G11
TCR-associated genes
Bt.28004.2.S1_a_atT cell receptor δ chain, V, D, and J regions, BTDV2T cell receptorD13656.1675
Bt.28004.2.A1_a_atT cell receptor δ chain, V, D, and J regions, BTDV2T cell receptorD13656.112.1
Bt.28007.1.A1_s_atT cell receptor δ chain, V, D, and J regions, BTDV6T cell receptorCK96920690.5
Bt.28732.1.S1_atT cell receptor δ chain, a part of V, D, J, and C regionsT cell receptorD90419.1776
Bt.28732.1.S1_s_atT cell receptor δ chain, a part of V, D, J, and C regionsT cell receptorD90419.1256
Bt.29691.1.S1_atT cell receptor δ chain variable region, BVd1.16T cell receptorU73383.12.6
Bt.29689.1.S1_s_atT cell receptor δ chain variable region, BVd1.21T cell receptorCK834180256
Bt.29695.1.A1_s_atT cell receptor γ chain variable region BVG3.1T cell receptorBE5884807.0
Bt.29695.1.A1_atT cell receptor γ chain variable region BVG3.1T cell receptorBE5884806.1
Bt.29695.1.S1_atT cell receptor γ chain variable region BVG3.1T cell receptorU73186.117.1
Bt.29694.1.S1_atT cell receptor γ chain variable region BVG3.2T cell receptorU73187.117.1
Bt.29693.1.S1_atT cell receptor γ chain variable region BVG7T cell receptorCK83617673.5
Bt.29693.1.A1_atT cell receptor γ chain variable region BVG7T cell receptorCK8361763.7
Surface molecules and receptors
Bt.7027.1.S1_atMHC class I-like family A1 (MHCLA1)MHC class IAF317556.13.3
Bt.1007.1.S1_atMHC class II DM β-chainMHC class IICK7730782.1
Bt.2227.1.S1_atHLA class II histocompatibility antigen, DZ α chainMHC class IIBI8491715.7
Bt.4482.1.S1_atMacrophage scavenger receptor type 1Binding and phagocytosis of bacteriaNM_174113.190.5
Bt.4482.2.S1_a_atMacrophage scavenger receptor type 1Binding and phagocytosis of bacteriaX51689.13.7
Bt.4482.2.S1_atMacrophage scavenger receptor type 1Binding and phagocytosis of bacteriaX51689.12.3
Bt.20836.1.S1_atMacrophage mannose receptor precursorBinds high mannose structures of pathogensCK94601618.4
Bt.23089.1.S1_atMacrophage mannose receptor precursorBinds high mannose structures of pathogensBF4403408.6
Bt.6850.1.S1_a_atCD3 δComponent of CD3X53269.12.1
Bt.2573.1.S1_atCD9Mediates platelet aggregation and activationNM_173900.27.5
Bt.248.1.S1_atCD38NAD glycohydrolase, augments B cell proliferationNM_175798.24.9
Bt.13496.2.S1_aCD63Lysosomal membrane proteinCK8495123.5
Bt.2334.1.S1_atMacrophage antigen CD68Macrosialin, macrophage-specific markerCK7741838.6
Bt.20940.1.S1_atT cell activation antigen (CD96 antigen)Expressed on activated T cellsCK7702912.8
Bt.4285.1.S1_atCD14Myeloid membrane protein (macrophage-specific)NM_174008.18.0
Bt.9030.1.S1_atToll-like receptor 4 (TLR4)Responds to LPS in conjunction with CD14NM_174198.33.7
Bt.8140.1.S1_atFc fragment of IgE, high-affinity IHigh-affinity receptor for IgENM_174537.14.9
Bt.284.1.S1_atFc fragment of IgG, high-affinity Ia (CD64)High-affinity receptor for IgGNM_174538.22.1
Bt.28015.1.S1_atFc-γ 2 receptorInhibits stimulationZ37506.14.0
Bt.4110.1.S1_atHistamine H1 receptorHistamine H1 receptorNM_174083.25.7
Bt.3843.1.S1_atImmunoglobulin J chainComponent of immunoglobulinNM_175773.19.2
Bt.13039.1.S1_atIntegrin, β 3 (CD61)Associates with glycoprotein IIb/IIIa or CD51CK8382383.3
Bt.21219.1.S1_atIntegrin α-E chain (CD103)Associates with β7 and binds E-cadherin in the gutCK9809752.6
Bt.9483.1.S1_atIntegrin α-D precursor (CD11d)Binds CD50; expressed on leukocytesBM3648732.3
Bt.27978.1.S1_atLeukocyte integrin α-M chain (CD11b)Binds ICAM-1, complement 3, fibrinogen (Mac1)AJ535320.16.5
Bt.1416.1.S1_atGalectin-3Galactose-specific lectin abundant on macrophages (Mac2)CK8496875.3
Bt.11241.1.S1_atE-cadherinA ligand for integrin α-E/β7CK9481765.3
Bt.5372.1.S1_atIntercellular adhesion molecule 1 (CD54)Binds LFA-1, Mac1NM_174348.22.5
Bt.4293.1.S1_atIntercellular adhesion molecule 3T cell molecule that binds CD209 on dendritic cellsNM_174349.13.0
Bt.10077.1.S3_atInterferon responsive factor 1Regulates response to IFN-γCK9609904.0
Bt.10077.1.S2_atInterferon responsive factor 1Regulates response to IFN-γCK9506853.0
Bt.5768.2.S1_atInterferon regulatory factor 7Role in virus-activated transcription of IFN-α genesBF7745132.0
Bt.4557.1.S1_atInterferon, α; receptorReceptor for IFN-αNM_174552.22.8
Bt.23148.1.S1_atInterleukin 11 receptor, αReceptor for IL-11CK9464082.3
Bt.7213.1.S1_atInterleukin 12 receptor, β2Receptor for IL-12 associated with IFN productionNM_174645.22.6
Bt.13851.1.S1_atInterleukin-13 receptor α-1 chain precursorReceptor for IL-13CK9664494.6
Bt.11174.1.S1_atKIR2DL1 Killer cell immunoglobulin-like receptorInhibits NK cell cytotoxicity on binding MHC I (CD158a)NM_174740.29.2
Bt.24545.1.S1_atNatural killer cell receptor group D variant 2Activating member of the NKG2 receptorsCK9520802.6
Bt.28588.2.A1_a_atNatural killer receptor 2B4 (CD244)Modulates other receptor-ligand interactions to activateCK9714832.6
Secreted products
Bt.8144.1.S1_atChemokine (C motif) ligand 1 (XCL1)Lymphocyte trafficking and development (Lymphoactin)NM_175716.26.5
Bt.2408.1.S1_s_atChemokine (C-C motif) ligand 2 (CCL2)Monocyte-chemoattractant protein-1NM_174006.264.0
Bt.2408.1.S1_atChemokine (C-C motif) ligand 2 (CCL2)Monocyte-chemoattractant protein-1NM_174006.226.0
Bt.154.1.S1_atChemokine (C-C motif) ligand 8 (CCL8)Monocyte-chemoattractant protein-2NM_174007.12.3
Bt.611.1.S2_atChemokine (C-X-C motif) ligand 1 (CXCL1)Neutrophil chemoattractant (GRO-α)NM_175700.15.3
Bt.611.1.S1_atChemokine (C-X-C motif) ligand 1 (CXCL1)Neutrophil chemoattractant (GRO-α)U95813.17.5
Bt.611.1.S1_x_atChemokine (C-X-C motif) ligand 1 (CXCL1)Neutrophil chemoattractant (GRO-α)U95813.17.0
Bt.610.1.A1_atChemokine (C-X-C motif) ligand 2 (CXCL2)Neutrophil chemoattractant (GRO-β)NM_174299.23.7
Bt.23093.1.S1_atChemokine (C-X-C motif) ligand 3 (CXCL3)Neutrophil chemoattractant (GRO-γ)CF9299895.7
Bt.7165.1.S1_atChemokine (C-X-C motif) ligand 6 (CXCL6)Neutrophil chemoattractant (GCP-2)NM_174300.22.3
Bt.8957.1.S1_atChemokine (C-X-C motif) receptor 4 (CXCR4)Receptor for SDF-1 chemokineNM_174301.23.3
Bt.191.1.S2_atInterleukin 1, αT cell and macrophage activationNM_174092.12.3
Bt.191.1.S1_atInterleukin-1, αT cell and macrophage activationM36182.12.5
Bt.4856.1.S2_atInterleukin 1, βT cell and macrophage activationNM_174093.13.0
Bt.4856.1.S1_atInterleukin 1, βT cell and macrophage activationM35589.12.6
Bt.423.1.S1_atInterleukin 4B cell activationNM_173921.23.0
Bt.5.1.S1_atInterleukin 5Eosinophil growth, differentiationNM_173922.110.6
Bt.12751.1.S1_atInterleukin 7Growth of pre-B cells and pre-T cellsNM_173924.22.0
Bt.155.1.S1_atInterleukin 8 (CXCL8)Lymphocyte-derived neutrophil-activating factorNM_173925.22.0
Bt.4723.1.S1_atInterleukin 10Potent suppressant of macrophage functionNM_174088.12.8
Bt.12928.1.S1_atInterleukin 13B cell growth, inhibits macrophage inflammatory cytokinesNM_174089.122.6
Bt.19162.1.A1_atInterleukin 13B cell growth, inhibits macrophage inflammatory cytokinesCB45626118.4
Bt.234.1.S1_atInterleukin 18Induces IFN-γ production; favors TH1NM_174091.22.8
Bt.26527.1.S1_a_atInterleukin-16 precursorChemoattractant for CD4 T cells, monocytes, eosinophilsCK8482363.0
Bt.12756.1.S1_atTumor necrosis factor-αLocal inflammation, endothelial activationNM_173966.13.3
Bt.9286.1.S1_atLPS-induced TNF-α factorLocal inflammation, endothelial activationCK9803422.0
Bt.29672.1.S1_atGranzyme A precursor (gzmA gene)Induces perforin-mediated apoptosisCK9507892.5
Bt.146.1.S1_atNeutrophil β-defensin 4Suppress cytokine production and NK cell activityAF014107.116.0
Bt.13125.1.S1Neutrophil β-defensin 4Suppress cytokine production and NK cell activityBM1063726.1
Bt.21431.2.S1_atLymphotoxin βStimulates lymph node developmentCB4287143.7
Bt.21431.3.S1_atLymphotoxin βStimulates lymph node developmentBE6680042.3
Bt.21431.1.S1_atLymphotoxin βStimulates lymph node developmentCK9481332.0
Bt.27067.1.A1_atLymphotoxin α precursorStimulates killing, endothelial activationCK7741129.9
Bt.24345.1.S1_atComplement component 2 precursorCleaves C3 and C5CK7723129.2
Bt.24345.2.S1_atComplement component 2 precursorCleaves C3 and C5BE4876144.9
Bt.8803.1.A1_atComplement C1r component precursorCleaves C1s to active proteaseCK9500264.3
Cytoplasmic molecules
Bt.142.1.S1_atNeutrophil cytosolic factor 1Part of NADPH oxidase; produces superoxideNM_174119.213.0
Bt.143.1.S1_atNeutrophil cytosolic factor 2Part of NADPH oxidase; produces superoxideNM_174120.212.1
Bt.7625.1.S1_a_atNeutrophil cytosolic factor 4Part of NADPH oxidase; produces superoxideCK7759622.5
Bt.23126.2.S1_atNitric oxide synthase 2AInducible nitric oxide synthaseAW6541108.0
Bt.23126.1.S1_atNitric oxide synthase 2AInducible nitric oxide synthaseCK8325074.3
Bt.8479.1.A1_atNO synthaseInducible nitric oxide synthaseBF0400873.0
Bt.8947.1.S1_atLegumainCysteine endoprotease that hydrolyzes asparaginyl bondsNM_174101.23.7
Bt.15758.1.S1_atProstaglandin-endoperoxide synthase 2Key enzyme in prostaglandin biosynthesis (COX2)NM_174445.22.6
Bt.13273.1.S1_atSuppressor of cytokine signaling 2Regulator of cytokine signal transductionNM_177523.22.5
Bt.22739.2.S1_atSuppressor of cytokine signaling 4Regulator of cytokine signal transductionCB4226582.0
Bt.23278.1.S1_atAllograft inflammatory factor 1Augments production of IL-6, IL-10, and IL-12NM_173985.26.1
Bt.12304.1.S1_atInterferon-stimulated protein, 15 kDaInduces B cell proliferation and T cell cytokine productionNM_174366.14.6
Bt.9308.1.S1_atLymphocyte phosphatase-associated phosphoproteinCytoplasmic tyrosine kinase necessary for TCR signalingBM2521173.3
Bt.26983.1.S1_atInterleukin-1β converting enzyme β isozymeCleaves and activates the inactive precursor of IL-1CK7767884.9
Bt.16623.1.A1_atNuclear factor of activated T cells 5, isoform cUp-regulates members of the TNF familyCB4221272.6
Bt.24855.2.S1_atTumor necrosis factor ligand superfamily member 13BInvolved in B cell proliferationBE7534402.5
Bt.18959.1.A1_atLymphocyte activation gene-3 (LAG-3/CD223)Binds to MHC class II; may be involved in down-regulationCB4522782.6
Bt.10855.1.S1_atRegulator of G-protein signaling 2 (RGS2)Inhibits G-protein signaling including chemokine signalsCB1691174.9
Bt.4781.1.S1_atA disintegrin and metalloproteinase domain10 (ADAM10)Cleaves L1 adhesion molecule to induce cell migrationNM_174496.22.1
Genes with higher transcript levels in αβ T cell clone 61.10.2D7
TCR-associated genes
Bt.28000.1.S1_atT-cell receptor γ chain V and J regionsT cell receptorBM362209−11.3b
Bt.4289.1.S1_atBovine T cell receptor α chain, and constant regionsT cell receptorCK960422−6.0
Bt.29765.1.S1_atT cell receptor β chain V-regionT cell receptorCK836454−337
Bt.1978.1.S1_a_atT cell receptor, β clusterT cell receptorCB172009−2.1
Bt.1978.1.S1_atT cell receptor, β clusterT cell receptorCB172009−2.6
Bt.1978.2.S1_x_atT cell receptor, β clusterT cell receptorCK775366−2.0
Bt.28013.1.S1_atBTGT1 mRNA for T cell receptor γ chainT cell receptorBE752633−27.9
Surface molecules and receptors
Bt.13087.1.S1_atCD6Binds CD166AB042274.1−4.3
Bt.48.1.S1_a_atCD28Binds CD80 and CD86NM_181004.1−24.3
Bt.48.3.S1_a_atCD28 isoform 2Binds CD80 and CD86AY064487.1−18.4
Bt.4497.1.S1_atCD5 antigen (p56–62)Expressed at high density on mature T cellsNM_173899.2−27.9
Bt.29099.1.S1_atT lymphocyte activation antigen CD80 precursorCostimulator, Ligand for CD28 and CTLA4CK955216−2.1
Bt.24707.1.S1_atCD86 mRNACostimulator, Ligand for CD28 and CTLA4AY533858.1−2.0
Bt.13097.1.S1_atCD86Costimulator, Ligand for CD28 and CTLA4AJ291475.1−2.5
Bt.3841.1.S1_atCD83 antigenDendritic cell-associated moleculeCK773094−8.0
Bt.3841.2.S1_atCD83 antigenDendritic cell-associated moleculeBE755445−9.9
Bt.10954.1.S1_atT cell surface antigen CD2 precursorBinds CD58 and activates T cellsCK774743−68.6
Bt.10954.2.S1_a_atT cell surface antigen CD2 precursorBinds CD58 and activates T cellsAW658942−73.5
Bt.10954.2.S1_atT cell surface antigen CD2 precursorBinds CD58 and activates T cellsAW658942−14.9
Bt.27979.1.S1_atCD4Coreceptor for MHC class IIAJ535319.1−9.9
Bt.79.1.S1_atCytotoxic T-lymphocyte-associated protein 4Negative regulator of T cell activationNM_174297.1−4.3
Bt.11174.3.S1KIR2DL1 Killer cell immunoglobulin-like receptorInhibits NK cell cytotoxicity on binding MHC IAF490400.1−4.9
Bt.22948.1.S1KIR3DL1 Killer cell immunoglobulin-like receptorInhibits NK cell cytotoxicity on binding MHC INM_181451.1−5.3
Bt.11174.2.S1KIR2DL1 NK receptor KIR3DL1-like protein pseudogeneInhibits NK cell cytotoxicity on binding MHC IAY075103.1−3.5
Bt.8547.1.S1_atSignaling lymphocytic activation molecule (CD150)Promotes T cell activation and IFN-γ productionNM_174184.2−3.5
Bt.22692.1.A1_atInterleukin-6 receptor precursor (CD126)IL-6 receptor αCK774531−5.7
Bt.12301.1.S1_atProstaglandin E receptor 2Decreased proliferation and cytokine releaseNM_174588.2−2.0
Bt.22749.1.A1_atProstaglandin F2 receptor negative regulatorAssociates with CD9 and CD81BP107094−2.1
Bt.22634.1.S1_atProstaglandin F2-α receptor regulatory proteinAssociates with CD9 and CD81BP109430−3.5
Bt.22634.2.A1_atProstaglandin F2-α receptor regulatory proteinAssociates with CD9 and CD81CB536196−3.0
Bt.22634.3.S1_atProstaglandin F2 receptor negative regulator precursorAssociates with CD9 and CD81CK946156−2.5
Bt.352.2.S1_atProstaglandin F2α receptor isoform-αReceptor for PGF2αAB083784.1−22.6
Bt.24531.1.S1_atInterleukin-4 receptor α chain precursor (CD124)IL-4 receptorAV666299−2.5
Bt.18375.1.S1_atTNF ligand superfamily member 5 (CD40L)Inducer of B cell proliferation and activationCB443472−97.0
Bt.49.1.S1_atTNF ligand superfamily member 5 (CD40L)Inducer of B cell proliferation and activationNM_174624.2−181
Bt.13148.1.S1_atVascular endothelial growth factor (VEGF)-receptor-1, fit-receptor proteinReceptor for VEGF with protein kinase activityX94263.1−3.3
Secreted products
Bt.523.1.S1_atInterleukin 12 p40Induces IFN-γ productionNM_174356.1−13.0
Bt.538.1.S1_atInterleukin 3Synergistic action in early hematopoiesisNM_173920.2−42.2
Bt.3686.1.S1_atInterleukin 6T cell and B cell growth and differentiationNM_173923.2−3.3
Bt.4336.1.S1_atComplement factor D precursorPlasma serine protease cleaves B when bound to C3bCK771764−4.6
Bt.4138.2.S1_atVascular endothelial growth factor (VEGF)Growth factor involved in angiogenesisCB450531−3.7
Bt.4138.1.S1_a_atVascular endothelial growth factor (VEGF)Growth factor involved in angiogenesisNM_174216.1−4.0
Cytoplasmic molecules
Bt.5154.1.S1_atHeat shock 70 kD protein 1Inducible isoforms of Hsp70NM_174550.1−2.0
Bt.5154.1.S1_sHeat shock 70 kD protein 1Inducible isoforms of Hsp70NM_174550.1−2.0
Bt.12241.1.S1_atLymphocyte-specific G protein-coupled receptor EBI1G-protein associated with CCR7CK770049−5.3
a

Gene transcript ratios are expressed as spot intensity for γδ T cell clone/spot intensity for αβ T cell clone.

b

When gene expression levels are higher in αβ T cells, the ratios are expressed as αβ:γδ T cells and as negative values. Mac1, Membrane-activated complex-1; GRO-α, growth-related oncogene-α; GCP-2, granulocyte chemotactic protein-2; SDF-1, stromal-derived factor-1; COX2, cyclooxygenase-2.

Table 3

Immune Function-Related Genes Differentially Regulated in the Oligonucleotide Array When Comparing γδT Cell Clone 61.1G11 and αβT Cell Clone 61.10.2D7

Gene IDGene nameDescriptionAccessionRatioa
Genes with higher transcript levels in γδ T cell clone 61.1G11
TCR-associated genes
Bt.28004.2.S1_a_atT cell receptor δ chain, V, D, and J regions, BTDV2T cell receptorD13656.1675
Bt.28004.2.A1_a_atT cell receptor δ chain, V, D, and J regions, BTDV2T cell receptorD13656.112.1
Bt.28007.1.A1_s_atT cell receptor δ chain, V, D, and J regions, BTDV6T cell receptorCK96920690.5
Bt.28732.1.S1_atT cell receptor δ chain, a part of V, D, J, and C regionsT cell receptorD90419.1776
Bt.28732.1.S1_s_atT cell receptor δ chain, a part of V, D, J, and C regionsT cell receptorD90419.1256
Bt.29691.1.S1_atT cell receptor δ chain variable region, BVd1.16T cell receptorU73383.12.6
Bt.29689.1.S1_s_atT cell receptor δ chain variable region, BVd1.21T cell receptorCK834180256
Bt.29695.1.A1_s_atT cell receptor γ chain variable region BVG3.1T cell receptorBE5884807.0
Bt.29695.1.A1_atT cell receptor γ chain variable region BVG3.1T cell receptorBE5884806.1
Bt.29695.1.S1_atT cell receptor γ chain variable region BVG3.1T cell receptorU73186.117.1
Bt.29694.1.S1_atT cell receptor γ chain variable region BVG3.2T cell receptorU73187.117.1
Bt.29693.1.S1_atT cell receptor γ chain variable region BVG7T cell receptorCK83617673.5
Bt.29693.1.A1_atT cell receptor γ chain variable region BVG7T cell receptorCK8361763.7
Surface molecules and receptors
Bt.7027.1.S1_atMHC class I-like family A1 (MHCLA1)MHC class IAF317556.13.3
Bt.1007.1.S1_atMHC class II DM β-chainMHC class IICK7730782.1
Bt.2227.1.S1_atHLA class II histocompatibility antigen, DZ α chainMHC class IIBI8491715.7
Bt.4482.1.S1_atMacrophage scavenger receptor type 1Binding and phagocytosis of bacteriaNM_174113.190.5
Bt.4482.2.S1_a_atMacrophage scavenger receptor type 1Binding and phagocytosis of bacteriaX51689.13.7
Bt.4482.2.S1_atMacrophage scavenger receptor type 1Binding and phagocytosis of bacteriaX51689.12.3
Bt.20836.1.S1_atMacrophage mannose receptor precursorBinds high mannose structures of pathogensCK94601618.4
Bt.23089.1.S1_atMacrophage mannose receptor precursorBinds high mannose structures of pathogensBF4403408.6
Bt.6850.1.S1_a_atCD3 δComponent of CD3X53269.12.1
Bt.2573.1.S1_atCD9Mediates platelet aggregation and activationNM_173900.27.5
Bt.248.1.S1_atCD38NAD glycohydrolase, augments B cell proliferationNM_175798.24.9
Bt.13496.2.S1_aCD63Lysosomal membrane proteinCK8495123.5
Bt.2334.1.S1_atMacrophage antigen CD68Macrosialin, macrophage-specific markerCK7741838.6
Bt.20940.1.S1_atT cell activation antigen (CD96 antigen)Expressed on activated T cellsCK7702912.8
Bt.4285.1.S1_atCD14Myeloid membrane protein (macrophage-specific)NM_174008.18.0
Bt.9030.1.S1_atToll-like receptor 4 (TLR4)Responds to LPS in conjunction with CD14NM_174198.33.7
Bt.8140.1.S1_atFc fragment of IgE, high-affinity IHigh-affinity receptor for IgENM_174537.14.9
Bt.284.1.S1_atFc fragment of IgG, high-affinity Ia (CD64)High-affinity receptor for IgGNM_174538.22.1
Bt.28015.1.S1_atFc-γ 2 receptorInhibits stimulationZ37506.14.0
Bt.4110.1.S1_atHistamine H1 receptorHistamine H1 receptorNM_174083.25.7
Bt.3843.1.S1_atImmunoglobulin J chainComponent of immunoglobulinNM_175773.19.2
Bt.13039.1.S1_atIntegrin, β 3 (CD61)Associates with glycoprotein IIb/IIIa or CD51CK8382383.3
Bt.21219.1.S1_atIntegrin α-E chain (CD103)Associates with β7 and binds E-cadherin in the gutCK9809752.6
Bt.9483.1.S1_atIntegrin α-D precursor (CD11d)Binds CD50; expressed on leukocytesBM3648732.3
Bt.27978.1.S1_atLeukocyte integrin α-M chain (CD11b)Binds ICAM-1, complement 3, fibrinogen (Mac1)AJ535320.16.5
Bt.1416.1.S1_atGalectin-3Galactose-specific lectin abundant on macrophages (Mac2)CK8496875.3
Bt.11241.1.S1_atE-cadherinA ligand for integrin α-E/β7CK9481765.3
Bt.5372.1.S1_atIntercellular adhesion molecule 1 (CD54)Binds LFA-1, Mac1NM_174348.22.5
Bt.4293.1.S1_atIntercellular adhesion molecule 3T cell molecule that binds CD209 on dendritic cellsNM_174349.13.0
Bt.10077.1.S3_atInterferon responsive factor 1Regulates response to IFN-γCK9609904.0
Bt.10077.1.S2_atInterferon responsive factor 1Regulates response to IFN-γCK9506853.0
Bt.5768.2.S1_atInterferon regulatory factor 7Role in virus-activated transcription of IFN-α genesBF7745132.0
Bt.4557.1.S1_atInterferon, α; receptorReceptor for IFN-αNM_174552.22.8
Bt.23148.1.S1_atInterleukin 11 receptor, αReceptor for IL-11CK9464082.3
Bt.7213.1.S1_atInterleukin 12 receptor, β2Receptor for IL-12 associated with IFN productionNM_174645.22.6
Bt.13851.1.S1_atInterleukin-13 receptor α-1 chain precursorReceptor for IL-13CK9664494.6
Bt.11174.1.S1_atKIR2DL1 Killer cell immunoglobulin-like receptorInhibits NK cell cytotoxicity on binding MHC I (CD158a)NM_174740.29.2
Bt.24545.1.S1_atNatural killer cell receptor group D variant 2Activating member of the NKG2 receptorsCK9520802.6
Bt.28588.2.A1_a_atNatural killer receptor 2B4 (CD244)Modulates other receptor-ligand interactions to activateCK9714832.6
Secreted products
Bt.8144.1.S1_atChemokine (C motif) ligand 1 (XCL1)Lymphocyte trafficking and development (Lymphoactin)NM_175716.26.5
Bt.2408.1.S1_s_atChemokine (C-C motif) ligand 2 (CCL2)Monocyte-chemoattractant protein-1NM_174006.264.0
Bt.2408.1.S1_atChemokine (C-C motif) ligand 2 (CCL2)Monocyte-chemoattractant protein-1NM_174006.226.0
Bt.154.1.S1_atChemokine (C-C motif) ligand 8 (CCL8)Monocyte-chemoattractant protein-2NM_174007.12.3
Bt.611.1.S2_atChemokine (C-X-C motif) ligand 1 (CXCL1)Neutrophil chemoattractant (GRO-α)NM_175700.15.3
Bt.611.1.S1_atChemokine (C-X-C motif) ligand 1 (CXCL1)Neutrophil chemoattractant (GRO-α)U95813.17.5
Bt.611.1.S1_x_atChemokine (C-X-C motif) ligand 1 (CXCL1)Neutrophil chemoattractant (GRO-α)U95813.17.0
Bt.610.1.A1_atChemokine (C-X-C motif) ligand 2 (CXCL2)Neutrophil chemoattractant (GRO-β)NM_174299.23.7
Bt.23093.1.S1_atChemokine (C-X-C motif) ligand 3 (CXCL3)Neutrophil chemoattractant (GRO-γ)CF9299895.7
Bt.7165.1.S1_atChemokine (C-X-C motif) ligand 6 (CXCL6)Neutrophil chemoattractant (GCP-2)NM_174300.22.3
Bt.8957.1.S1_atChemokine (C-X-C motif) receptor 4 (CXCR4)Receptor for SDF-1 chemokineNM_174301.23.3
Bt.191.1.S2_atInterleukin 1, αT cell and macrophage activationNM_174092.12.3
Bt.191.1.S1_atInterleukin-1, αT cell and macrophage activationM36182.12.5
Bt.4856.1.S2_atInterleukin 1, βT cell and macrophage activationNM_174093.13.0
Bt.4856.1.S1_atInterleukin 1, βT cell and macrophage activationM35589.12.6
Bt.423.1.S1_atInterleukin 4B cell activationNM_173921.23.0
Bt.5.1.S1_atInterleukin 5Eosinophil growth, differentiationNM_173922.110.6
Bt.12751.1.S1_atInterleukin 7Growth of pre-B cells and pre-T cellsNM_173924.22.0
Bt.155.1.S1_atInterleukin 8 (CXCL8)Lymphocyte-derived neutrophil-activating factorNM_173925.22.0
Bt.4723.1.S1_atInterleukin 10Potent suppressant of macrophage functionNM_174088.12.8
Bt.12928.1.S1_atInterleukin 13B cell growth, inhibits macrophage inflammatory cytokinesNM_174089.122.6
Bt.19162.1.A1_atInterleukin 13B cell growth, inhibits macrophage inflammatory cytokinesCB45626118.4
Bt.234.1.S1_atInterleukin 18Induces IFN-γ production; favors TH1NM_174091.22.8
Bt.26527.1.S1_a_atInterleukin-16 precursorChemoattractant for CD4 T cells, monocytes, eosinophilsCK8482363.0
Bt.12756.1.S1_atTumor necrosis factor-αLocal inflammation, endothelial activationNM_173966.13.3
Bt.9286.1.S1_atLPS-induced TNF-α factorLocal inflammation, endothelial activationCK9803422.0
Bt.29672.1.S1_atGranzyme A precursor (gzmA gene)Induces perforin-mediated apoptosisCK9507892.5
Bt.146.1.S1_atNeutrophil β-defensin 4Suppress cytokine production and NK cell activityAF014107.116.0
Bt.13125.1.S1Neutrophil β-defensin 4Suppress cytokine production and NK cell activityBM1063726.1
Bt.21431.2.S1_atLymphotoxin βStimulates lymph node developmentCB4287143.7
Bt.21431.3.S1_atLymphotoxin βStimulates lymph node developmentBE6680042.3
Bt.21431.1.S1_atLymphotoxin βStimulates lymph node developmentCK9481332.0
Bt.27067.1.A1_atLymphotoxin α precursorStimulates killing, endothelial activationCK7741129.9
Bt.24345.1.S1_atComplement component 2 precursorCleaves C3 and C5CK7723129.2
Bt.24345.2.S1_atComplement component 2 precursorCleaves C3 and C5BE4876144.9
Bt.8803.1.A1_atComplement C1r component precursorCleaves C1s to active proteaseCK9500264.3
Cytoplasmic molecules
Bt.142.1.S1_atNeutrophil cytosolic factor 1Part of NADPH oxidase; produces superoxideNM_174119.213.0
Bt.143.1.S1_atNeutrophil cytosolic factor 2Part of NADPH oxidase; produces superoxideNM_174120.212.1
Bt.7625.1.S1_a_atNeutrophil cytosolic factor 4Part of NADPH oxidase; produces superoxideCK7759622.5
Bt.23126.2.S1_atNitric oxide synthase 2AInducible nitric oxide synthaseAW6541108.0
Bt.23126.1.S1_atNitric oxide synthase 2AInducible nitric oxide synthaseCK8325074.3
Bt.8479.1.A1_atNO synthaseInducible nitric oxide synthaseBF0400873.0
Bt.8947.1.S1_atLegumainCysteine endoprotease that hydrolyzes asparaginyl bondsNM_174101.23.7
Bt.15758.1.S1_atProstaglandin-endoperoxide synthase 2Key enzyme in prostaglandin biosynthesis (COX2)NM_174445.22.6
Bt.13273.1.S1_atSuppressor of cytokine signaling 2Regulator of cytokine signal transductionNM_177523.22.5
Bt.22739.2.S1_atSuppressor of cytokine signaling 4Regulator of cytokine signal transductionCB4226582.0
Bt.23278.1.S1_atAllograft inflammatory factor 1Augments production of IL-6, IL-10, and IL-12NM_173985.26.1
Bt.12304.1.S1_atInterferon-stimulated protein, 15 kDaInduces B cell proliferation and T cell cytokine productionNM_174366.14.6
Bt.9308.1.S1_atLymphocyte phosphatase-associated phosphoproteinCytoplasmic tyrosine kinase necessary for TCR signalingBM2521173.3
Bt.26983.1.S1_atInterleukin-1β converting enzyme β isozymeCleaves and activates the inactive precursor of IL-1CK7767884.9
Bt.16623.1.A1_atNuclear factor of activated T cells 5, isoform cUp-regulates members of the TNF familyCB4221272.6
Bt.24855.2.S1_atTumor necrosis factor ligand superfamily member 13BInvolved in B cell proliferationBE7534402.5
Bt.18959.1.A1_atLymphocyte activation gene-3 (LAG-3/CD223)Binds to MHC class II; may be involved in down-regulationCB4522782.6
Bt.10855.1.S1_atRegulator of G-protein signaling 2 (RGS2)Inhibits G-protein signaling including chemokine signalsCB1691174.9
Bt.4781.1.S1_atA disintegrin and metalloproteinase domain10 (ADAM10)Cleaves L1 adhesion molecule to induce cell migrationNM_174496.22.1
Genes with higher transcript levels in αβ T cell clone 61.10.2D7
TCR-associated genes
Bt.28000.1.S1_atT-cell receptor γ chain V and J regionsT cell receptorBM362209−11.3b
Bt.4289.1.S1_atBovine T cell receptor α chain, and constant regionsT cell receptorCK960422−6.0
Bt.29765.1.S1_atT cell receptor β chain V-regionT cell receptorCK836454−337
Bt.1978.1.S1_a_atT cell receptor, β clusterT cell receptorCB172009−2.1
Bt.1978.1.S1_atT cell receptor, β clusterT cell receptorCB172009−2.6
Bt.1978.2.S1_x_atT cell receptor, β clusterT cell receptorCK775366−2.0
Bt.28013.1.S1_atBTGT1 mRNA for T cell receptor γ chainT cell receptorBE752633−27.9
Surface molecules and receptors
Bt.13087.1.S1_atCD6Binds CD166AB042274.1−4.3
Bt.48.1.S1_a_atCD28Binds CD80 and CD86NM_181004.1−24.3
Bt.48.3.S1_a_atCD28 isoform 2Binds CD80 and CD86AY064487.1−18.4
Bt.4497.1.S1_atCD5 antigen (p56–62)Expressed at high density on mature T cellsNM_173899.2−27.9
Bt.29099.1.S1_atT lymphocyte activation antigen CD80 precursorCostimulator, Ligand for CD28 and CTLA4CK955216−2.1
Bt.24707.1.S1_atCD86 mRNACostimulator, Ligand for CD28 and CTLA4AY533858.1−2.0
Bt.13097.1.S1_atCD86Costimulator, Ligand for CD28 and CTLA4AJ291475.1−2.5
Bt.3841.1.S1_atCD83 antigenDendritic cell-associated moleculeCK773094−8.0
Bt.3841.2.S1_atCD83 antigenDendritic cell-associated moleculeBE755445−9.9
Bt.10954.1.S1_atT cell surface antigen CD2 precursorBinds CD58 and activates T cellsCK774743−68.6
Bt.10954.2.S1_a_atT cell surface antigen CD2 precursorBinds CD58 and activates T cellsAW658942−73.5
Bt.10954.2.S1_atT cell surface antigen CD2 precursorBinds CD58 and activates T cellsAW658942−14.9
Bt.27979.1.S1_atCD4Coreceptor for MHC class IIAJ535319.1−9.9
Bt.79.1.S1_atCytotoxic T-lymphocyte-associated protein 4Negative regulator of T cell activationNM_174297.1−4.3
Bt.11174.3.S1KIR2DL1 Killer cell immunoglobulin-like receptorInhibits NK cell cytotoxicity on binding MHC IAF490400.1−4.9
Bt.22948.1.S1KIR3DL1 Killer cell immunoglobulin-like receptorInhibits NK cell cytotoxicity on binding MHC INM_181451.1−5.3
Bt.11174.2.S1KIR2DL1 NK receptor KIR3DL1-like protein pseudogeneInhibits NK cell cytotoxicity on binding MHC IAY075103.1−3.5
Bt.8547.1.S1_atSignaling lymphocytic activation molecule (CD150)Promotes T cell activation and IFN-γ productionNM_174184.2−3.5
Bt.22692.1.A1_atInterleukin-6 receptor precursor (CD126)IL-6 receptor αCK774531−5.7
Bt.12301.1.S1_atProstaglandin E receptor 2Decreased proliferation and cytokine releaseNM_174588.2−2.0
Bt.22749.1.A1_atProstaglandin F2 receptor negative regulatorAssociates with CD9 and CD81BP107094−2.1
Bt.22634.1.S1_atProstaglandin F2-α receptor regulatory proteinAssociates with CD9 and CD81BP109430−3.5
Bt.22634.2.A1_atProstaglandin F2-α receptor regulatory proteinAssociates with CD9 and CD81CB536196−3.0
Bt.22634.3.S1_atProstaglandin F2 receptor negative regulator precursorAssociates with CD9 and CD81CK946156−2.5
Bt.352.2.S1_atProstaglandin F2α receptor isoform-αReceptor for PGF2αAB083784.1−22.6
Bt.24531.1.S1_atInterleukin-4 receptor α chain precursor (CD124)IL-4 receptorAV666299−2.5
Bt.18375.1.S1_atTNF ligand superfamily member 5 (CD40L)Inducer of B cell proliferation and activationCB443472−97.0
Bt.49.1.S1_atTNF ligand superfamily member 5 (CD40L)Inducer of B cell proliferation and activationNM_174624.2−181
Bt.13148.1.S1_atVascular endothelial growth factor (VEGF)-receptor-1, fit-receptor proteinReceptor for VEGF with protein kinase activityX94263.1−3.3
Secreted products
Bt.523.1.S1_atInterleukin 12 p40Induces IFN-γ productionNM_174356.1−13.0
Bt.538.1.S1_atInterleukin 3Synergistic action in early hematopoiesisNM_173920.2−42.2
Bt.3686.1.S1_atInterleukin 6T cell and B cell growth and differentiationNM_173923.2−3.3
Bt.4336.1.S1_atComplement factor D precursorPlasma serine protease cleaves B when bound to C3bCK771764−4.6
Bt.4138.2.S1_atVascular endothelial growth factor (VEGF)Growth factor involved in angiogenesisCB450531−3.7
Bt.4138.1.S1_a_atVascular endothelial growth factor (VEGF)Growth factor involved in angiogenesisNM_174216.1−4.0
Cytoplasmic molecules
Bt.5154.1.S1_atHeat shock 70 kD protein 1Inducible isoforms of Hsp70NM_174550.1−2.0
Bt.5154.1.S1_sHeat shock 70 kD protein 1Inducible isoforms of Hsp70NM_174550.1−2.0
Bt.12241.1.S1_atLymphocyte-specific G protein-coupled receptor EBI1G-protein associated with CCR7CK770049−5.3
Gene IDGene nameDescriptionAccessionRatioa
Genes with higher transcript levels in γδ T cell clone 61.1G11
TCR-associated genes
Bt.28004.2.S1_a_atT cell receptor δ chain, V, D, and J regions, BTDV2T cell receptorD13656.1675
Bt.28004.2.A1_a_atT cell receptor δ chain, V, D, and J regions, BTDV2T cell receptorD13656.112.1
Bt.28007.1.A1_s_atT cell receptor δ chain, V, D, and J regions, BTDV6T cell receptorCK96920690.5
Bt.28732.1.S1_atT cell receptor δ chain, a part of V, D, J, and C regionsT cell receptorD90419.1776
Bt.28732.1.S1_s_atT cell receptor δ chain, a part of V, D, J, and C regionsT cell receptorD90419.1256
Bt.29691.1.S1_atT cell receptor δ chain variable region, BVd1.16T cell receptorU73383.12.6
Bt.29689.1.S1_s_atT cell receptor δ chain variable region, BVd1.21T cell receptorCK834180256
Bt.29695.1.A1_s_atT cell receptor γ chain variable region BVG3.1T cell receptorBE5884807.0
Bt.29695.1.A1_atT cell receptor γ chain variable region BVG3.1T cell receptorBE5884806.1
Bt.29695.1.S1_atT cell receptor γ chain variable region BVG3.1T cell receptorU73186.117.1
Bt.29694.1.S1_atT cell receptor γ chain variable region BVG3.2T cell receptorU73187.117.1
Bt.29693.1.S1_atT cell receptor γ chain variable region BVG7T cell receptorCK83617673.5
Bt.29693.1.A1_atT cell receptor γ chain variable region BVG7T cell receptorCK8361763.7
Surface molecules and receptors
Bt.7027.1.S1_atMHC class I-like family A1 (MHCLA1)MHC class IAF317556.13.3
Bt.1007.1.S1_atMHC class II DM β-chainMHC class IICK7730782.1
Bt.2227.1.S1_atHLA class II histocompatibility antigen, DZ α chainMHC class IIBI8491715.7
Bt.4482.1.S1_atMacrophage scavenger receptor type 1Binding and phagocytosis of bacteriaNM_174113.190.5
Bt.4482.2.S1_a_atMacrophage scavenger receptor type 1Binding and phagocytosis of bacteriaX51689.13.7
Bt.4482.2.S1_atMacrophage scavenger receptor type 1Binding and phagocytosis of bacteriaX51689.12.3
Bt.20836.1.S1_atMacrophage mannose receptor precursorBinds high mannose structures of pathogensCK94601618.4
Bt.23089.1.S1_atMacrophage mannose receptor precursorBinds high mannose structures of pathogensBF4403408.6
Bt.6850.1.S1_a_atCD3 δComponent of CD3X53269.12.1
Bt.2573.1.S1_atCD9Mediates platelet aggregation and activationNM_173900.27.5
Bt.248.1.S1_atCD38NAD glycohydrolase, augments B cell proliferationNM_175798.24.9
Bt.13496.2.S1_aCD63Lysosomal membrane proteinCK8495123.5
Bt.2334.1.S1_atMacrophage antigen CD68Macrosialin, macrophage-specific markerCK7741838.6
Bt.20940.1.S1_atT cell activation antigen (CD96 antigen)Expressed on activated T cellsCK7702912.8
Bt.4285.1.S1_atCD14Myeloid membrane protein (macrophage-specific)NM_174008.18.0
Bt.9030.1.S1_atToll-like receptor 4 (TLR4)Responds to LPS in conjunction with CD14NM_174198.33.7
Bt.8140.1.S1_atFc fragment of IgE, high-affinity IHigh-affinity receptor for IgENM_174537.14.9
Bt.284.1.S1_atFc fragment of IgG, high-affinity Ia (CD64)High-affinity receptor for IgGNM_174538.22.1
Bt.28015.1.S1_atFc-γ 2 receptorInhibits stimulationZ37506.14.0
Bt.4110.1.S1_atHistamine H1 receptorHistamine H1 receptorNM_174083.25.7
Bt.3843.1.S1_atImmunoglobulin J chainComponent of immunoglobulinNM_175773.19.2
Bt.13039.1.S1_atIntegrin, β 3 (CD61)Associates with glycoprotein IIb/IIIa or CD51CK8382383.3
Bt.21219.1.S1_atIntegrin α-E chain (CD103)Associates with β7 and binds E-cadherin in the gutCK9809752.6
Bt.9483.1.S1_atIntegrin α-D precursor (CD11d)Binds CD50; expressed on leukocytesBM3648732.3
Bt.27978.1.S1_atLeukocyte integrin α-M chain (CD11b)Binds ICAM-1, complement 3, fibrinogen (Mac1)AJ535320.16.5
Bt.1416.1.S1_atGalectin-3Galactose-specific lectin abundant on macrophages (Mac2)CK8496875.3
Bt.11241.1.S1_atE-cadherinA ligand for integrin α-E/β7CK9481765.3
Bt.5372.1.S1_atIntercellular adhesion molecule 1 (CD54)Binds LFA-1, Mac1NM_174348.22.5
Bt.4293.1.S1_atIntercellular adhesion molecule 3T cell molecule that binds CD209 on dendritic cellsNM_174349.13.0
Bt.10077.1.S3_atInterferon responsive factor 1Regulates response to IFN-γCK9609904.0
Bt.10077.1.S2_atInterferon responsive factor 1Regulates response to IFN-γCK9506853.0
Bt.5768.2.S1_atInterferon regulatory factor 7Role in virus-activated transcription of IFN-α genesBF7745132.0
Bt.4557.1.S1_atInterferon, α; receptorReceptor for IFN-αNM_174552.22.8
Bt.23148.1.S1_atInterleukin 11 receptor, αReceptor for IL-11CK9464082.3
Bt.7213.1.S1_atInterleukin 12 receptor, β2Receptor for IL-12 associated with IFN productionNM_174645.22.6
Bt.13851.1.S1_atInterleukin-13 receptor α-1 chain precursorReceptor for IL-13CK9664494.6
Bt.11174.1.S1_atKIR2DL1 Killer cell immunoglobulin-like receptorInhibits NK cell cytotoxicity on binding MHC I (CD158a)NM_174740.29.2
Bt.24545.1.S1_atNatural killer cell receptor group D variant 2Activating member of the NKG2 receptorsCK9520802.6
Bt.28588.2.A1_a_atNatural killer receptor 2B4 (CD244)Modulates other receptor-ligand interactions to activateCK9714832.6
Secreted products
Bt.8144.1.S1_atChemokine (C motif) ligand 1 (XCL1)Lymphocyte trafficking and development (Lymphoactin)NM_175716.26.5
Bt.2408.1.S1_s_atChemokine (C-C motif) ligand 2 (CCL2)Monocyte-chemoattractant protein-1NM_174006.264.0
Bt.2408.1.S1_atChemokine (C-C motif) ligand 2 (CCL2)Monocyte-chemoattractant protein-1NM_174006.226.0
Bt.154.1.S1_atChemokine (C-C motif) ligand 8 (CCL8)Monocyte-chemoattractant protein-2NM_174007.12.3
Bt.611.1.S2_atChemokine (C-X-C motif) ligand 1 (CXCL1)Neutrophil chemoattractant (GRO-α)NM_175700.15.3
Bt.611.1.S1_atChemokine (C-X-C motif) ligand 1 (CXCL1)Neutrophil chemoattractant (GRO-α)U95813.17.5
Bt.611.1.S1_x_atChemokine (C-X-C motif) ligand 1 (CXCL1)Neutrophil chemoattractant (GRO-α)U95813.17.0
Bt.610.1.A1_atChemokine (C-X-C motif) ligand 2 (CXCL2)Neutrophil chemoattractant (GRO-β)NM_174299.23.7
Bt.23093.1.S1_atChemokine (C-X-C motif) ligand 3 (CXCL3)Neutrophil chemoattractant (GRO-γ)CF9299895.7
Bt.7165.1.S1_atChemokine (C-X-C motif) ligand 6 (CXCL6)Neutrophil chemoattractant (GCP-2)NM_174300.22.3
Bt.8957.1.S1_atChemokine (C-X-C motif) receptor 4 (CXCR4)Receptor for SDF-1 chemokineNM_174301.23.3
Bt.191.1.S2_atInterleukin 1, αT cell and macrophage activationNM_174092.12.3
Bt.191.1.S1_atInterleukin-1, αT cell and macrophage activationM36182.12.5
Bt.4856.1.S2_atInterleukin 1, βT cell and macrophage activationNM_174093.13.0
Bt.4856.1.S1_atInterleukin 1, βT cell and macrophage activationM35589.12.6
Bt.423.1.S1_atInterleukin 4B cell activationNM_173921.23.0
Bt.5.1.S1_atInterleukin 5Eosinophil growth, differentiationNM_173922.110.6
Bt.12751.1.S1_atInterleukin 7Growth of pre-B cells and pre-T cellsNM_173924.22.0
Bt.155.1.S1_atInterleukin 8 (CXCL8)Lymphocyte-derived neutrophil-activating factorNM_173925.22.0
Bt.4723.1.S1_atInterleukin 10Potent suppressant of macrophage functionNM_174088.12.8
Bt.12928.1.S1_atInterleukin 13B cell growth, inhibits macrophage inflammatory cytokinesNM_174089.122.6
Bt.19162.1.A1_atInterleukin 13B cell growth, inhibits macrophage inflammatory cytokinesCB45626118.4
Bt.234.1.S1_atInterleukin 18Induces IFN-γ production; favors TH1NM_174091.22.8
Bt.26527.1.S1_a_atInterleukin-16 precursorChemoattractant for CD4 T cells, monocytes, eosinophilsCK8482363.0
Bt.12756.1.S1_atTumor necrosis factor-αLocal inflammation, endothelial activationNM_173966.13.3
Bt.9286.1.S1_atLPS-induced TNF-α factorLocal inflammation, endothelial activationCK9803422.0
Bt.29672.1.S1_atGranzyme A precursor (gzmA gene)Induces perforin-mediated apoptosisCK9507892.5
Bt.146.1.S1_atNeutrophil β-defensin 4Suppress cytokine production and NK cell activityAF014107.116.0
Bt.13125.1.S1Neutrophil β-defensin 4Suppress cytokine production and NK cell activityBM1063726.1
Bt.21431.2.S1_atLymphotoxin βStimulates lymph node developmentCB4287143.7
Bt.21431.3.S1_atLymphotoxin βStimulates lymph node developmentBE6680042.3
Bt.21431.1.S1_atLymphotoxin βStimulates lymph node developmentCK9481332.0
Bt.27067.1.A1_atLymphotoxin α precursorStimulates killing, endothelial activationCK7741129.9
Bt.24345.1.S1_atComplement component 2 precursorCleaves C3 and C5CK7723129.2
Bt.24345.2.S1_atComplement component 2 precursorCleaves C3 and C5BE4876144.9
Bt.8803.1.A1_atComplement C1r component precursorCleaves C1s to active proteaseCK9500264.3
Cytoplasmic molecules
Bt.142.1.S1_atNeutrophil cytosolic factor 1Part of NADPH oxidase; produces superoxideNM_174119.213.0
Bt.143.1.S1_atNeutrophil cytosolic factor 2Part of NADPH oxidase; produces superoxideNM_174120.212.1
Bt.7625.1.S1_a_atNeutrophil cytosolic factor 4Part of NADPH oxidase; produces superoxideCK7759622.5
Bt.23126.2.S1_atNitric oxide synthase 2AInducible nitric oxide synthaseAW6541108.0
Bt.23126.1.S1_atNitric oxide synthase 2AInducible nitric oxide synthaseCK8325074.3
Bt.8479.1.A1_atNO synthaseInducible nitric oxide synthaseBF0400873.0
Bt.8947.1.S1_atLegumainCysteine endoprotease that hydrolyzes asparaginyl bondsNM_174101.23.7
Bt.15758.1.S1_atProstaglandin-endoperoxide synthase 2Key enzyme in prostaglandin biosynthesis (COX2)NM_174445.22.6
Bt.13273.1.S1_atSuppressor of cytokine signaling 2Regulator of cytokine signal transductionNM_177523.22.5
Bt.22739.2.S1_atSuppressor of cytokine signaling 4Regulator of cytokine signal transductionCB4226582.0
Bt.23278.1.S1_atAllograft inflammatory factor 1Augments production of IL-6, IL-10, and IL-12NM_173985.26.1
Bt.12304.1.S1_atInterferon-stimulated protein, 15 kDaInduces B cell proliferation and T cell cytokine productionNM_174366.14.6
Bt.9308.1.S1_atLymphocyte phosphatase-associated phosphoproteinCytoplasmic tyrosine kinase necessary for TCR signalingBM2521173.3
Bt.26983.1.S1_atInterleukin-1β converting enzyme β isozymeCleaves and activates the inactive precursor of IL-1CK7767884.9
Bt.16623.1.A1_atNuclear factor of activated T cells 5, isoform cUp-regulates members of the TNF familyCB4221272.6
Bt.24855.2.S1_atTumor necrosis factor ligand superfamily member 13BInvolved in B cell proliferationBE7534402.5
Bt.18959.1.A1_atLymphocyte activation gene-3 (LAG-3/CD223)Binds to MHC class II; may be involved in down-regulationCB4522782.6
Bt.10855.1.S1_atRegulator of G-protein signaling 2 (RGS2)Inhibits G-protein signaling including chemokine signalsCB1691174.9
Bt.4781.1.S1_atA disintegrin and metalloproteinase domain10 (ADAM10)Cleaves L1 adhesion molecule to induce cell migrationNM_174496.22.1
Genes with higher transcript levels in αβ T cell clone 61.10.2D7
TCR-associated genes
Bt.28000.1.S1_atT-cell receptor γ chain V and J regionsT cell receptorBM362209−11.3b
Bt.4289.1.S1_atBovine T cell receptor α chain, and constant regionsT cell receptorCK960422−6.0
Bt.29765.1.S1_atT cell receptor β chain V-regionT cell receptorCK836454−337
Bt.1978.1.S1_a_atT cell receptor, β clusterT cell receptorCB172009−2.1
Bt.1978.1.S1_atT cell receptor, β clusterT cell receptorCB172009−2.6
Bt.1978.2.S1_x_atT cell receptor, β clusterT cell receptorCK775366−2.0
Bt.28013.1.S1_atBTGT1 mRNA for T cell receptor γ chainT cell receptorBE752633−27.9
Surface molecules and receptors
Bt.13087.1.S1_atCD6Binds CD166AB042274.1−4.3
Bt.48.1.S1_a_atCD28Binds CD80 and CD86NM_181004.1−24.3
Bt.48.3.S1_a_atCD28 isoform 2Binds CD80 and CD86AY064487.1−18.4
Bt.4497.1.S1_atCD5 antigen (p56–62)Expressed at high density on mature T cellsNM_173899.2−27.9
Bt.29099.1.S1_atT lymphocyte activation antigen CD80 precursorCostimulator, Ligand for CD28 and CTLA4CK955216−2.1
Bt.24707.1.S1_atCD86 mRNACostimulator, Ligand for CD28 and CTLA4AY533858.1−2.0
Bt.13097.1.S1_atCD86Costimulator, Ligand for CD28 and CTLA4AJ291475.1−2.5
Bt.3841.1.S1_atCD83 antigenDendritic cell-associated moleculeCK773094−8.0
Bt.3841.2.S1_atCD83 antigenDendritic cell-associated moleculeBE755445−9.9
Bt.10954.1.S1_atT cell surface antigen CD2 precursorBinds CD58 and activates T cellsCK774743−68.6
Bt.10954.2.S1_a_atT cell surface antigen CD2 precursorBinds CD58 and activates T cellsAW658942−73.5
Bt.10954.2.S1_atT cell surface antigen CD2 precursorBinds CD58 and activates T cellsAW658942−14.9
Bt.27979.1.S1_atCD4Coreceptor for MHC class IIAJ535319.1−9.9
Bt.79.1.S1_atCytotoxic T-lymphocyte-associated protein 4Negative regulator of T cell activationNM_174297.1−4.3
Bt.11174.3.S1KIR2DL1 Killer cell immunoglobulin-like receptorInhibits NK cell cytotoxicity on binding MHC IAF490400.1−4.9
Bt.22948.1.S1KIR3DL1 Killer cell immunoglobulin-like receptorInhibits NK cell cytotoxicity on binding MHC INM_181451.1−5.3
Bt.11174.2.S1KIR2DL1 NK receptor KIR3DL1-like protein pseudogeneInhibits NK cell cytotoxicity on binding MHC IAY075103.1−3.5
Bt.8547.1.S1_atSignaling lymphocytic activation molecule (CD150)Promotes T cell activation and IFN-γ productionNM_174184.2−3.5
Bt.22692.1.A1_atInterleukin-6 receptor precursor (CD126)IL-6 receptor αCK774531−5.7
Bt.12301.1.S1_atProstaglandin E receptor 2Decreased proliferation and cytokine releaseNM_174588.2−2.0
Bt.22749.1.A1_atProstaglandin F2 receptor negative regulatorAssociates with CD9 and CD81BP107094−2.1
Bt.22634.1.S1_atProstaglandin F2-α receptor regulatory proteinAssociates with CD9 and CD81BP109430−3.5
Bt.22634.2.A1_atProstaglandin F2-α receptor regulatory proteinAssociates with CD9 and CD81CB536196−3.0
Bt.22634.3.S1_atProstaglandin F2 receptor negative regulator precursorAssociates with CD9 and CD81CK946156−2.5
Bt.352.2.S1_atProstaglandin F2α receptor isoform-αReceptor for PGF2αAB083784.1−22.6
Bt.24531.1.S1_atInterleukin-4 receptor α chain precursor (CD124)IL-4 receptorAV666299−2.5
Bt.18375.1.S1_atTNF ligand superfamily member 5 (CD40L)Inducer of B cell proliferation and activationCB443472−97.0
Bt.49.1.S1_atTNF ligand superfamily member 5 (CD40L)Inducer of B cell proliferation and activationNM_174624.2−181
Bt.13148.1.S1_atVascular endothelial growth factor (VEGF)-receptor-1, fit-receptor proteinReceptor for VEGF with protein kinase activityX94263.1−3.3
Secreted products
Bt.523.1.S1_atInterleukin 12 p40Induces IFN-γ productionNM_174356.1−13.0
Bt.538.1.S1_atInterleukin 3Synergistic action in early hematopoiesisNM_173920.2−42.2
Bt.3686.1.S1_atInterleukin 6T cell and B cell growth and differentiationNM_173923.2−3.3
Bt.4336.1.S1_atComplement factor D precursorPlasma serine protease cleaves B when bound to C3bCK771764−4.6
Bt.4138.2.S1_atVascular endothelial growth factor (VEGF)Growth factor involved in angiogenesisCB450531−3.7
Bt.4138.1.S1_a_atVascular endothelial growth factor (VEGF)Growth factor involved in angiogenesisNM_174216.1−4.0
Cytoplasmic molecules
Bt.5154.1.S1_atHeat shock 70 kD protein 1Inducible isoforms of Hsp70NM_174550.1−2.0
Bt.5154.1.S1_sHeat shock 70 kD protein 1Inducible isoforms of Hsp70NM_174550.1−2.0
Bt.12241.1.S1_atLymphocyte-specific G protein-coupled receptor EBI1G-protein associated with CCR7CK770049−5.3
a

Gene transcript ratios are expressed as spot intensity for γδ T cell clone/spot intensity for αβ T cell clone.

b

When gene expression levels are higher in αβ T cells, the ratios are expressed as αβ:γδ T cells and as negative values. Mac1, Membrane-activated complex-1; GRO-α, growth-related oncogene-α; GCP-2, granulocyte chemotactic protein-2; SDF-1, stromal-derived factor-1; COX2, cyclooxygenase-2.

Table 4

Real-Time RT-PCR Analysis of Selected Immune Function Genes When Comparing γδ T Cell Clone 61.1G11 with αβ T Cell Clone 61.10.2D7

GeneMicroarray predictionNormalized γδ real-time PCRaNormalized αβ real-time PCRRatiob ± sd
CCL264/26c3,46435.497.612.1
CCL31.01,9483,052−1.6d0.2
CCL51.26180−1.30.2
CCL82.3115373.10.8
CCR51.017.037.7−2.30.3
CD11a1.23.006.84−2.30.3
CD11b6.50.360.049.11.4
CD11c1.016.29.021.80.2
CD148.00.130.071.70.1
CD181.41.432.17−1.50.1
CD688.61.080.144.81.1
CXCL17.5/7.0/5.354.218.13.00.4
CXCL23.788.816.85.30.3
CXCL62.325351.94.90.5
CXCL82.03.271.871.80.1
CXCR43.31.510.821.80.7
FasL1.917.615.31.20.2
Galectin-35.32.370.722.380.1
Granzyme A2.55792952.00.1
Granulysin1.39.37.971.20.1
ICAM-12.513159.12.20.1
ICAM-33.02.791.162.40.1
IFN-α receptor 12.80.700.91−1.30.5
IFN-γ−1.32951,657−5.60.9
IL-1α2.5/2.364.055.81.20.2
IL-1β3.0/2.62071281.60.1
IL-102.830.15.965.11.3
IL-182.85.403.851.40.3
Interferon response factor 13.0/4.04.543.121.50.2
Integrin β33.33.791.652.31.1
MMR18.4/8.61.180.0710.92.6
MSR190.5/2.3/3.753.02.0725.63.8
Perforin1.038.250.5−1.30.2
Selenoprotein P2390.220.102.30.6
TLR2−20.471.58−3.32.5
TLR43.712.14.832.50.3
TNF-α3.319.284.754.10.3
XCL16.54,34131014.02.0
GeneMicroarray predictionNormalized γδ real-time PCRaNormalized αβ real-time PCRRatiob ± sd
CCL264/26c3,46435.497.612.1
CCL31.01,9483,052−1.6d0.2
CCL51.26180−1.30.2
CCL82.3115373.10.8
CCR51.017.037.7−2.30.3
CD11a1.23.006.84−2.30.3
CD11b6.50.360.049.11.4
CD11c1.016.29.021.80.2
CD148.00.130.071.70.1
CD181.41.432.17−1.50.1
CD688.61.080.144.81.1
CXCL17.5/7.0/5.354.218.13.00.4
CXCL23.788.816.85.30.3
CXCL62.325351.94.90.5
CXCL82.03.271.871.80.1
CXCR43.31.510.821.80.7
FasL1.917.615.31.20.2
Galectin-35.32.370.722.380.1
Granzyme A2.55792952.00.1
Granulysin1.39.37.971.20.1
ICAM-12.513159.12.20.1
ICAM-33.02.791.162.40.1
IFN-α receptor 12.80.700.91−1.30.5
IFN-γ−1.32951,657−5.60.9
IL-1α2.5/2.364.055.81.20.2
IL-1β3.0/2.62071281.60.1
IL-102.830.15.965.11.3
IL-182.85.403.851.40.3
Interferon response factor 13.0/4.04.543.121.50.2
Integrin β33.33.791.652.31.1
MMR18.4/8.61.180.0710.92.6
MSR190.5/2.3/3.753.02.0725.63.8
Perforin1.038.250.5−1.30.2
Selenoprotein P2390.220.102.30.6
TLR2−20.471.58−3.32.5
TLR43.712.14.832.50.3
TNF-α3.319.284.754.10.3
XCL16.54,34131014.02.0
a

Real-time RT-PCR value when compared with a standard curve for each gene and normalized to 18S ribosomal RNA for each sample.

b

Ratio of normalized, real-time RT-PCR values of γδ T cell clone 61.1G11 to αβ T cell clone 61.10.2D7.

c

When more than one prediction was made for gene expression by the oligonucleotide microarray, each is listed.

d

When gene expression levels are higher in αβ T cells, the ratios are expressed as αβ:γδ T cells and as negative values.

Table 4

Real-Time RT-PCR Analysis of Selected Immune Function Genes When Comparing γδ T Cell Clone 61.1G11 with αβ T Cell Clone 61.10.2D7

GeneMicroarray predictionNormalized γδ real-time PCRaNormalized αβ real-time PCRRatiob ± sd
CCL264/26c3,46435.497.612.1
CCL31.01,9483,052−1.6d0.2
CCL51.26180−1.30.2
CCL82.3115373.10.8
CCR51.017.037.7−2.30.3
CD11a1.23.006.84−2.30.3
CD11b6.50.360.049.11.4
CD11c1.016.29.021.80.2
CD148.00.130.071.70.1
CD181.41.432.17−1.50.1
CD688.61.080.144.81.1
CXCL17.5/7.0/5.354.218.13.00.4
CXCL23.788.816.85.30.3
CXCL62.325351.94.90.5
CXCL82.03.271.871.80.1
CXCR43.31.510.821.80.7
FasL1.917.615.31.20.2
Galectin-35.32.370.722.380.1
Granzyme A2.55792952.00.1
Granulysin1.39.37.971.20.1
ICAM-12.513159.12.20.1
ICAM-33.02.791.162.40.1
IFN-α receptor 12.80.700.91−1.30.5
IFN-γ−1.32951,657−5.60.9
IL-1α2.5/2.364.055.81.20.2
IL-1β3.0/2.62071281.60.1
IL-102.830.15.965.11.3
IL-182.85.403.851.40.3
Interferon response factor 13.0/4.04.543.121.50.2
Integrin β33.33.791.652.31.1
MMR18.4/8.61.180.0710.92.6
MSR190.5/2.3/3.753.02.0725.63.8
Perforin1.038.250.5−1.30.2
Selenoprotein P2390.220.102.30.6
TLR2−20.471.58−3.32.5
TLR43.712.14.832.50.3
TNF-α3.319.284.754.10.3
XCL16.54,34131014.02.0
GeneMicroarray predictionNormalized γδ real-time PCRaNormalized αβ real-time PCRRatiob ± sd
CCL264/26c3,46435.497.612.1
CCL31.01,9483,052−1.6d0.2
CCL51.26180−1.30.2
CCL82.3115373.10.8
CCR51.017.037.7−2.30.3
CD11a1.23.006.84−2.30.3
CD11b6.50.360.049.11.4
CD11c1.016.29.021.80.2
CD148.00.130.071.70.1
CD181.41.432.17−1.50.1
CD688.61.080.144.81.1
CXCL17.5/7.0/5.354.218.13.00.4
CXCL23.788.816.85.30.3
CXCL62.325351.94.90.5
CXCL82.03.271.871.80.1
CXCR43.31.510.821.80.7
FasL1.917.615.31.20.2
Galectin-35.32.370.722.380.1
Granzyme A2.55792952.00.1
Granulysin1.39.37.971.20.1
ICAM-12.513159.12.20.1
ICAM-33.02.791.162.40.1
IFN-α receptor 12.80.700.91−1.30.5
IFN-γ−1.32951,657−5.60.9
IL-1α2.5/2.364.055.81.20.2
IL-1β3.0/2.62071281.60.1
IL-102.830.15.965.11.3
IL-182.85.403.851.40.3
Interferon response factor 13.0/4.04.543.121.50.2
Integrin β33.33.791.652.31.1
MMR18.4/8.61.180.0710.92.6
MSR190.5/2.3/3.753.02.0725.63.8
Perforin1.038.250.5−1.30.2
Selenoprotein P2390.220.102.30.6
TLR2−20.471.58−3.32.5
TLR43.712.14.832.50.3
TNF-α3.319.284.754.10.3
XCL16.54,34131014.02.0
a

Real-time RT-PCR value when compared with a standard curve for each gene and normalized to 18S ribosomal RNA for each sample.

b

Ratio of normalized, real-time RT-PCR values of γδ T cell clone 61.1G11 to αβ T cell clone 61.10.2D7.

c

When more than one prediction was made for gene expression by the oligonucleotide microarray, each is listed.

d

When gene expression levels are higher in αβ T cells, the ratios are expressed as αβ:γδ T cells and as negative values.

Table 5

Comparison of Cytokine and NO Produced by γδ and αβ T Cells

MediatorLevels of mediator in the supernatanta
γδ T cell clone 61.1G11αβ T cell clone 61.10.2D7
TNF-α1.1 ± 0.03 ng/mlb<80 pg/ml
IFN-γ60.5 ± 29 ng/ml483 ± 120 ng/ml
IL-101.42 ± 0.078 U/ml<0.5 U/ml
Nitrite1.6 ± 0 μM0.71 ± 0 μM
MediatorLevels of mediator in the supernatanta
γδ T cell clone 61.1G11αβ T cell clone 61.10.2D7
TNF-α1.1 ± 0.03 ng/mlb<80 pg/ml
IFN-γ60.5 ± 29 ng/ml483 ± 120 ng/ml
IL-101.42 ± 0.078 U/ml<0.5 U/ml
Nitrite1.6 ± 0 μM0.71 ± 0 μM
a

T cell clones were harvested 7 days after stimulation with TCGF, antigen, and APC, washed, and cultured for an additional 24 h without APC and with Con A and IL-2. Cytokine levels in cell supernatants were determined by ELISA, and nitrite was measured by the Griess assay. The limit of TNF-α detection was 80 pg/ml, and that of IL-10 was 0.5 U/ml. Results are presented as a mean ± 1 sd of duplicate cultures.

b

When mediators were compared between clones, values in boldface type were shown to be significantly higher using a one-tailed Student’s t-test.

Table 5

Comparison of Cytokine and NO Produced by γδ and αβ T Cells

MediatorLevels of mediator in the supernatanta
γδ T cell clone 61.1G11αβ T cell clone 61.10.2D7
TNF-α1.1 ± 0.03 ng/mlb<80 pg/ml
IFN-γ60.5 ± 29 ng/ml483 ± 120 ng/ml
IL-101.42 ± 0.078 U/ml<0.5 U/ml
Nitrite1.6 ± 0 μM0.71 ± 0 μM
MediatorLevels of mediator in the supernatanta
γδ T cell clone 61.1G11αβ T cell clone 61.10.2D7
TNF-α1.1 ± 0.03 ng/mlb<80 pg/ml
IFN-γ60.5 ± 29 ng/ml483 ± 120 ng/ml
IL-101.42 ± 0.078 U/ml<0.5 U/ml
Nitrite1.6 ± 0 μM0.71 ± 0 μM
a

T cell clones were harvested 7 days after stimulation with TCGF, antigen, and APC, washed, and cultured for an additional 24 h without APC and with Con A and IL-2. Cytokine levels in cell supernatants were determined by ELISA, and nitrite was measured by the Griess assay. The limit of TNF-α detection was 80 pg/ml, and that of IL-10 was 0.5 U/ml. Results are presented as a mean ± 1 sd of duplicate cultures.

b

When mediators were compared between clones, values in boldface type were shown to be significantly higher using a one-tailed Student’s t-test.

Figure 2

Flow cytometric analysis of γδ T cell clone 61.1G11 and αβ T cell clone 61.10.2D7 for surface expression of CD11b. Results are presented as histograms showing staining of clones 61.1G11 (a) and 61.10.2D7 (b) with mAb MM10A specific for CD11b (black line) and no primary antibody (silver area).

Table 6

Real-Time RT-PCR Analysis of Selected Immune Function Genes When Comparing γδ T Cell Clone 61.3G3 and αβ T Cell Clone 61.3H5 or WC1+ and CD4+ Cells Selected from PBMC

GeneT cell clonesSelected PBMC
Normalized γδ real-time PCRa valueNormalized αβ real-time PCR valueRatiob ± sdNormalized γδ real-time PCRa valueNormalized αβ real-time PCR valueRatioc ± sd
CCL2d6472.40269.645.83.370.359.62.4
CCL80.0580.20−3.40.20.0540.000413547.5
CD685.090.4012.70.90.240.01121.87.4
CD11b0.930.02438.76.20.050.0077.12.4
CXCL11501.28117.28.935.60.4972.718.8
CXCL28925.11174.514.23323.22103.124.9
CXCL699611.785.111.094.31.0689.018.7
CXCL83.670.0661.22.41.050.01955.312.6
Galectin-31.640.1510.90.00.210.0972.20.5
Granzyme A63.9639−10.00.41.361.321.00.3
ICAM13.462.041.70.21.380.168.61.8
ICAM30.650.641.00.070.280.0348.21.9
IFN-γ14569253−6.4e0.72350.231022251
IL-104.705.58−1.20.15.610.3217.54.8
Integrin β347.726.01.80.257.022.92.50.6
MMR0.220.045.51.40.0760.0135.81.2
MSR11.620.374.40.80.930.721.30.4
TLR47.535.571.40.13.451.003.50.8
TNF-α27.213.02.10.113.50.7518.04.6
XCL-122.70.0045675469.10.490.0047104.226.0
GeneT cell clonesSelected PBMC
Normalized γδ real-time PCRa valueNormalized αβ real-time PCR valueRatiob ± sdNormalized γδ real-time PCRa valueNormalized αβ real-time PCR valueRatioc ± sd
CCL2d6472.40269.645.83.370.359.62.4
CCL80.0580.20−3.40.20.0540.000413547.5
CD685.090.4012.70.90.240.01121.87.4
CD11b0.930.02438.76.20.050.0077.12.4
CXCL11501.28117.28.935.60.4972.718.8
CXCL28925.11174.514.23323.22103.124.9
CXCL699611.785.111.094.31.0689.018.7
CXCL83.670.0661.22.41.050.01955.312.6
Galectin-31.640.1510.90.00.210.0972.20.5
Granzyme A63.9639−10.00.41.361.321.00.3
ICAM13.462.041.70.21.380.168.61.8
ICAM30.650.641.00.070.280.0348.21.9
IFN-γ14569253−6.4e0.72350.231022251
IL-104.705.58−1.20.15.610.3217.54.8
Integrin β347.726.01.80.257.022.92.50.6
MMR0.220.045.51.40.0760.0135.81.2
MSR11.620.374.40.80.930.721.30.4
TLR47.535.571.40.13.451.003.50.8
TNF-α27.213.02.10.113.50.7518.04.6
XCL-122.70.0045675469.10.490.0047104.226.0
a

Real-time RT-PCR value when compared with a standard curve for each gene and normalized to 18S ribosomal RNA for each sample.

b

Ratio of normalized, real-time RT-PCR values of γδ T cell clone 61.3G3 to αβ T cell clone 61.3H5.

c

Ratio of normalized, real-time RT-PCR values of sorted WC1+PBMC to CD4+PBMC.

d

Bolded values are those that have real-time PCR patterns of expression similar to clones 61.1G11 and 61.10.2D7.

e

When gene expression levels are higher in αβ T cells, the ratios are expressed as αβ:γδ T cells and as negative values.

Table 6

Real-Time RT-PCR Analysis of Selected Immune Function Genes When Comparing γδ T Cell Clone 61.3G3 and αβ T Cell Clone 61.3H5 or WC1+ and CD4+ Cells Selected from PBMC

GeneT cell clonesSelected PBMC
Normalized γδ real-time PCRa valueNormalized αβ real-time PCR valueRatiob ± sdNormalized γδ real-time PCRa valueNormalized αβ real-time PCR valueRatioc ± sd
CCL2d6472.40269.645.83.370.359.62.4
CCL80.0580.20−3.40.20.0540.000413547.5
CD685.090.4012.70.90.240.01121.87.4
CD11b0.930.02438.76.20.050.0077.12.4
CXCL11501.28117.28.935.60.4972.718.8
CXCL28925.11174.514.23323.22103.124.9
CXCL699611.785.111.094.31.0689.018.7
CXCL83.670.0661.22.41.050.01955.312.6
Galectin-31.640.1510.90.00.210.0972.20.5
Granzyme A63.9639−10.00.41.361.321.00.3
ICAM13.462.041.70.21.380.168.61.8
ICAM30.650.641.00.070.280.0348.21.9
IFN-γ14569253−6.4e0.72350.231022251
IL-104.705.58−1.20.15.610.3217.54.8
Integrin β347.726.01.80.257.022.92.50.6
MMR0.220.045.51.40.0760.0135.81.2
MSR11.620.374.40.80.930.721.30.4
TLR47.535.571.40.13.451.003.50.8
TNF-α27.213.02.10.113.50.7518.04.6
XCL-122.70.0045675469.10.490.0047104.226.0
GeneT cell clonesSelected PBMC
Normalized γδ real-time PCRa valueNormalized αβ real-time PCR valueRatiob ± sdNormalized γδ real-time PCRa valueNormalized αβ real-time PCR valueRatioc ± sd
CCL2d6472.40269.645.83.370.359.62.4
CCL80.0580.20−3.40.20.0540.000413547.5
CD685.090.4012.70.90.240.01121.87.4
CD11b0.930.02438.76.20.050.0077.12.4
CXCL11501.28117.28.935.60.4972.718.8
CXCL28925.11174.514.23323.22103.124.9
CXCL699611.785.111.094.31.0689.018.7
CXCL83.670.0661.22.41.050.01955.312.6
Galectin-31.640.1510.90.00.210.0972.20.5
Granzyme A63.9639−10.00.41.361.321.00.3
ICAM13.462.041.70.21.380.168.61.8
ICAM30.650.641.00.070.280.0348.21.9
IFN-γ14569253−6.4e0.72350.231022251
IL-104.705.58−1.20.15.610.3217.54.8
Integrin β347.726.01.80.257.022.92.50.6
MMR0.220.045.51.40.0760.0135.81.2
MSR11.620.374.40.80.930.721.30.4
TLR47.535.571.40.13.451.003.50.8
TNF-α27.213.02.10.113.50.7518.04.6
XCL-122.70.0045675469.10.490.0047104.226.0
a

Real-time RT-PCR value when compared with a standard curve for each gene and normalized to 18S ribosomal RNA for each sample.

b

Ratio of normalized, real-time RT-PCR values of γδ T cell clone 61.3G3 to αβ T cell clone 61.3H5.

c

Ratio of normalized, real-time RT-PCR values of sorted WC1+PBMC to CD4+PBMC.

d

Bolded values are those that have real-time PCR patterns of expression similar to clones 61.1G11 and 61.10.2D7.

e

When gene expression levels are higher in αβ T cells, the ratios are expressed as αβ:γδ T cells and as negative values.

ACKNOWLEDGMENTS

This work was supported by National Institutes of Health, National Institute of Allergy and Infectious Diseases, Grant K08 AI53594 and U.S. Department of Agriculture, National Research Initiative Competitive Grants Program, Grant 00-52100-9612. We are grateful to Kim Kegerreis, Daming Zhu, and Shelley Whidbee for excellent technical assistance, to Jayne Hope and Chris Howard for providing reagents for the IL-10 ELISA and mAb CC8, and to Dale Godson (VIDO) for providing reagents for the TNF-α ELISA.

REFERENCES

1.

Brenner
,
M. B.
,
McLean
,
J.
,
Dialynas
,
D. P.
,
Strominger
,
J. L.
,
Smith
,
J. A.
,
Owen
,
F. L.
,
Seidman
,
J. G.
,
Ip
,
S.
,
Rosen
,
F.
,
Krangel
,
M. S.
(
1986
)
Identification of a putative second T-cell receptor
.
Nature
 
322
,
145
-
149
.

2.

Hayday
,
A. C.
(
2000
)
γδ Cells: a right time and a right place for a conserved third way of protection
.
Annu. Rev. Immunol.
 
18
,
975
-
1026
.

3.

Hein
,
W. R.
,
Dudler
,
L.
,
Morris
,
B.
(
1990
)
Differential peripheral expansion and in vivo antigen reactivity of αβ and γδ T cells emigrating from the early fetal lamb thymus
.
Eur. J. Immunol.
 
20
,
1805
-
1813
.

4.

Hein
,
W. R.
,
Mackay
,
C. R.
(
1991
)
Prominence of γδ T cells in the ruminant immune system
.
Immunol. Today
 
12
,
30
-
34
.

5.

MacHugh
,
N. D.
,
Mburu
,
J. K.
,
Carol
,
M. J.
,
Wyatt
,
C. R.
,
Orden
,
J. A.
,
Davis
,
W. C.
(
1997
)
Identification of two distinct subsets of bovine γδ T cells with unique cell surface phenotype and tissue distribution
.
Immunology
 
92
,
340
-
345
.

6.

Wijngaard
,
P. L.
,
Metzelaar
,
M. J.
,
MacHugh
,
N. D.
,
Morrison
,
W. I.
,
Clevers
,
H. C.
(
1992
)
Molecular characterization of the WC1 antigen expressed specifically on bovine CD4–CD8–γδ T lymphocytes
.
J. Immunol.
 
149
,
3273
-
3277
.

7.

Carr
,
M. M.
,
Howard
,
C. J.
,
Sopp
,
P.
,
Manser
,
J. M.
,
Parsons
,
K. R.
(
1994
)
Expression on porcine γδ lymphocytes of a phylogenetically conserved surface antigen previously restricted in expression to ruminant γδ T lymphocytes
.
Immunology
 
81
,
36
-
40
.

8.

Lahmers
,
K. K.
,
Norimine
,
J.
,
Abrahamsen
,
M. S.
,
Palmer
,
G. H.
,
Brown
,
W. C.
(
2005
)
The CD4+ T cell immunodominant Anaplasma marginale major surface protein 2 stimulates γδ T cell clones that express unique T cell receptors
.
J. Leukoc. Biol.
 
77
,
199
-
208
.

9.

Brown
,
W. C.
,
Davis
,
W. C.
,
Tuo
,
W.
(
1996
)
Human interleukin-12 upregulates proliferation and interferon-γ production by parasite antigenstimulated Th cell clones and γ/δ T cells of cattle
.
Ann. N. Y. Acad. Sci.
 
795
,
321
-
324
.

10.

Kabelitz
,
D.
,
Wesch
,
D.
(
2003
)
Features and functions of γδ T lymphocytes: focus on chemokines and their receptors
.
Crit. Rev. Immunol.
 
23
,
339
-
370
.

11.

Wilson
,
E.
,
Aydintug
,
M. K.
,
Jutila
,
M. A.
(
1999
)
A circulating bovine γδ T cell subset, which is found in large numbers in the spleen, accumulates inefficiently in an artificial site of inflammation: correlation with lack of expression of E-selectin ligands and L-selectin
.
J. Immunol.
 
162
,
4914
-
4919
.

12.

Hedges
,
J. F.
,
Cockrell
,
D.
,
Jackiw
,
L.
,
Meissner
,
N.
,
Jutila
,
M. A.
(
2003
)
Differential mRNA expression in circulating γδ T lymphocyte subsets defines unique tissue-specific functions
.
J. Leukoc. Biol.
 
73
,
306
-
314
.

13.

Meissner
,
N.
,
Radke
,
J.
,
Hedges
,
J. F.
,
White
,
M.
,
Behnke
,
M.
,
Bertolino
,
S.
,
Abrahamsen
,
M.
,
Jutila
,
M. A.
(
2003
)
Serial analysis of gene expression in circulating γδ T cell subsets defines distinct immunoregulatory phenotypes and unexpected gene expression profiles
.
J. Immunol.
 
170
,
356
-
364
.

14.

Siegrist
,
C. A.
(
2001
)
Neonatal and early life vaccinology
.
Vaccine
 
19
,
3331
-
3346
.

15.

Collins
,
R. A.
,
Werling
,
D.
,
Duggan
,
S. E.
,
Bland
,
A. P.
,
Parsons
,
K. R.
,
Howard
,
C. J.
(
1998
)
γδ T cells present antigen to CD4+ αβ T cells
.
J. Leukoc. Biol.
 
63
,
707
-
714
.

16.

Brandes
,
M.
,
Willimann
,
K.
,
Moser
,
B.
(
2005
)
Professional antigen-presentation function by human γδ T cells
.
Science
 
309
,
264
-
268
.

17.

Graff
,
J. C.
,
Behnke
,
M.
,
Radke
,
J.
,
White
,
M.
,
Jutila
,
M. A.
(
2006
)
A comprehensive SAGE database for the analysis of γδ T cells
.
Int. Immunol.
 
18
,
613
-
626
.

18.

Brown
,
W. C.
,
Palmer
,
G. H.
,
Brayton
,
K. A.
,
Meeus
,
P. F.
,
Barbet
,
A. F.
,
Kegerreis
,
K. A.
,
McGuire
,
T. C.
(
2004
)
CD4+ T lymphocytes from Anaplasma marginale major surface protein 2 (MSP2) vaccinees recognize naturally processed epitopes conserved in MSP3
.
Infect. Immun.
 
72
,
3688
-
3692
.

19.

Brown
,
W. C.
,
McGuire
,
T. C.
,
Zhu
,
D.
,
Lewin
,
H. A.
,
Sosnow
,
J.
,
Palmer
,
G. H.
(
2001
)
Highly conserved regions of the immunodominant major surface protein 2 of the genogroup II ehrlichial pathogen Anaplasma marginale are rich in naturally derived CD4+ T lymphocyte epitopes that elicit strong recall responses
.
J. Immunol.
 
166
,
1114
-
1124
.

20.

Brown
,
W. C.
,
Zhao
,
S.
,
Rice-Ficht
,
A. C.
,
Logan
,
K. S.
,
Woods
,
V. M.
(
1992
)
Bovine helper T cell clones recognize five distinct epitopes on Babesia bovis merozoite antigens
.
Infect. Immun.
 
60
,
4364
-
4372
.

21.

Bennett
,
S.
,
Riley
,
E. M.
(
1992
)
The statistical analysis of data from immunoepidemiological studies
.
J. Immunol. Methods
 
146
,
229
-
239
.

22.

Hubbell
,
E.
,
Liu
,
W. M.
,
Mei
,
R.
(
2002
)
Robust estimators for expression analysis
.
Bioinformatics
 
18
,
1585
-
1592
.

23.

Liu
,
W. M.
,
Mei
,
R.
,
Di
,
X.
,
Ryder
,
T. B.
,
Hubbell
,
E.
,
Dee
,
S.
,
Webster
,
T. A.
,
Harrington
,
C. A.
,
Ho
,
M. H.
,
Baid
,
J.
,
Smeekens
,
S. P.
(
2002
)
Analysis of high density expression microarrays with signed-rank call algorithms
.
Bioinformatics
 
18
,
1593
-
1599
.

24.

Kwong
,
L. S.
,
Hope
,
J. C.
,
Thom
,
M. L.
,
Sopp
,
P.
,
Duggan
,
S.
,
Bembridge
,
G. P.
,
Howard
,
C. J.
(
2002
)
Development of an ELISA for bovine IL-10
.
Vet. Immunol. Immunopathol.
 
85
,
213
-
223
.

25.

Brown
,
W. C.
,
McElwain
,
T. F.
,
Palmer
,
G. H.
,
Chantler
,
S. E.
,
Estes
,
D. M.
(
1999
)
Bovine CD4+ T-lymphocyte clones specific for rhoptryassociated protein 1 of Babesia bigemina stimulate enhanced immunoglobulin G1 (IgG1) and IgG2 synthesis
.
Infect. Immun.
 
67
,
155
-
164
.

26.

Beyer
,
J. C.
,
Stich
,
R. W.
,
Hoover
,
D. S.
,
Brown
,
W. C.
,
Cheevers
,
W. P.
(
1998
)
Cloning and expression of caprine interferon-γ
.
Gene
 
210
,
103
-
108
.

27.

Ellis
,
J. A.
,
Godson
,
D.
,
Campos
,
M.
,
Sileghem
,
M.
,
Babiuk
,
L. A.
(
1993
)
Capture immunoassay for ruminant tumor necrosis factor-α: comparison with bioassay
.
Vet. Immunol. Immunopathol.
 
35
,
289
-
300
.

28.

Shoda
,
L. K.
,
Kegerreis
,
K. A.
,
Suarez
,
C. E.
,
Roditi
,
I.
,
Corral
,
R. S.
,
Bertot
,
G. M.
,
Norimine
,
J.
,
Brown
,
W. C.
(
2001
)
DNA from protozoan parasites Babesia bovis, Trypanosoma cruzi, and T. brucei is mitogenic for B lymphocytes and stimulates macrophage expression of interleukin-12, tumor necrosis factor α, and nitric oxide
.
Infect. Immun.
 
69
,
2162
-
2171
.

29.

Shoda
,
L. K.
,
Palmer
,
G. H.
,
Florin-Christensen
,
J.
,
Florin-Christensen
,
M.
,
Godson
,
D. L.
,
Brown
,
W. C.
(
2000
)
Babesia bovis-stimulated macrophages express interleukin-1β, interleukin-12, tumor necrosis factor α, and nitric oxide and inhibit parasite replication in vitro
.
Infect. Immun.
 
68
,
5139
-
5145
.

30.

Abbott
,
J. R.
,
Palmer
,
G. H.
,
Howard
,
C. J.
,
Hope
,
J. C.
,
Brown
,
W. C.
(
2004
)
Anaplasma marginale major surface protein 2 CD4+–T-cell epitopes are evenly distributed in conserved and hypervariable regions (HVR), whereas linear B-cell epitopes are predominantly located in the HVR
.
Infect. Immun.
 
72
,
7360
-
7366
.

31.

Abbott
,
J. R.
,
Palmer
,
G. H.
,
Kegerreis
,
K. A.
,
Hetrick
,
P. F.
,
Howard
,
C. J.
,
Hope
,
J. C.
,
Brown
,
W. C.
(
2005
)
Rapid and long-term disappearance of CD4+ T lymphocyte responses specific for Anaplasma marginale major surface protein-2 (MSP2) in MSP2 vaccinates following challenge with live
 
A. marginale. J. Immunol.
 
174
,
6702
-
6715
.

32.

Adams
,
E. J.
,
Chien
,
Y. H.
,
Garcia
,
K. C.
(
2005
)
Structure of a γδ T cell receptor in complex with the nonclassical MHC T22
.
Science
 
308
,
227
-
231
.

33.

Shin
,
S.
,
El-Diwany
,
R.
,
Schaffert
,
S.
,
Adams
,
E. J.
,
Garcia
,
K. C.
,
Pereira
,
P.
,
Chien
,
Y. H.
(
2005
)
Antigen recognition determinants of γδ T cell receptors
.
Science
 
308
,
252
-
255
.

34.

Born
,
W. K.
,
Lahn
,
M.
,
Takeda
,
K.
,
Kanehiro
,
A.
,
O'Brien
,
R. L.
,
Gelfand
,
E. W.
(
2000
)
Role of γδ T cells in protecting normal airway function
.
Respir. Res.
 
1
,
151
-
158
.

35.

Jameson
,
J.
,
Ugarte
,
K.
,
Chen
,
N.
,
Yachi
,
P.
,
Fuchs
,
E.
,
Boismenu
,
R.
,
Havran
,
W. L.
(
2002
)
A role for skin γδ T cells in wound repair
.
Science
 
296
,
747
-
749
.

36.

Havran
,
W. L.
(
2000
)
A role for epithelial γδ T cells in tissue repair
.
Immunol. Res.
 
21
,
63
-
69
.

37.

Curfs
,
J. H.
,
Meis
,
J. F.
,
Hoogkamp-Korstanje
,
J. A.
(
1997
)
A primer on cytokines: sources, receptors, effects, and inducers
.
Clin. Microbiol. Rev.
 
10
,
742
-
780
.

38.

Hedges
,
J. F.
,
Lubick
,
K. L.
,
Jutila
,
M. A.
(
2005
)
γδ T cells respond directly to pathogen-associated molecular patterns
.
J. Immunol.
 
174
,
6045
-
6053
.

39.

Yamashita
,
S.
,
Tanaka
,
Y.
,
Tsutsumi
,
S.
,
Aburatani
,
H.
,
Minato
,
N.
,
Ihara
,
S.
(
2005
)
Analysis of mechanism for human γδ T cell recognition of nonpeptide antigens
.
Biochem. Biophys. Res. Commun.
 
334
,
349
-
360
.

40.

Szabo
,
S. J.
,
Sullivan
,
B. M.
,
Peng
,
S. L.
,
Glimcher
,
L. H.
(
2003
)
Molecular mechanisms regulating Th1 immune responses
.
Annu. Rev. Immunol.
 
21
,
713
-
758
.

41.

Atre
,
N.
,
Thomas
,
L.
,
Mistry
,
R.
,
Pathak
,
K.
,
Chiplunkar
,
S.
(
2006
)
Role of nitric oxide in heat shock protein induced apoptosis of γδ T cells
.
Int. J. Cancer
 
119
,
1368
-
1376
.

42.

Taylor-Robinson
,
A. W.
,
Liew
,
F. Y.
,
Severn
,
A.
,
Xu
,
D.
,
McSorley
,
S. J.
,
Garside
,
P.
,
Padron
,
J.
,
Phillips
,
R. S.
(
1994
)
Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells
.
Eur. J. Immunol.
 
24
,
980
-
984
.

43.

Roby
,
T. O.
,
Gates
,
D. W.
,
Mott
,
L. O.
(
1961
)
The comparative susceptibility of calves and adult cattle to bovine anaplasmosis
.
Am. J. Vet. Res.
 
22
,
982
-
985
.

44.

Jones
,
W. E.
,
Kliewer
,
I. O.
,
Norman
,
B. B.
,
Brock
,
W. E.
(
1968
)
Anaplasma marginale infection in young and aged cattle
.
Am. J. Vet. Res.
 
29
,
535
-
544
.

45.

Brown
,
W. C.
,
Norimine
,
J.
,
Knowles
,
D. P.
,
Goff
,
W. L.
(
2006
)
Immune control of Babesia bovis infection
.
Vet. Parasitol.
 
138
,
75
-
87
.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/pages/standard-publication-reuse-rights)